Lineage-	O
and	O
stage-specific	O
expression	O
of	O
runt	B-protein
box	I-protein
polypeptides	I-protein
in	O
primitive	O
and	O
definitive	O
hematopoiesis	O
.	O

Translocations	O
involving	O
the	O
human	B-DNA
CBFA2	I-DNA
locus	I-DNA
have	O
been	O
associated	O
with	O
leukemia	O
.	O

This	O
gene	O
,	O
originally	O
named	O
AML1	B-DNA
,	O
is	O
a	O
human	O
homologue	O
of	O
the	O
Drosophila	B-DNA
gene	I-DNA
runt	I-DNA
that	O
controls	O
early	O
events	O
in	O
fly	O
embryogenesis	O
.	O

To	O
clarify	O
the	O
role	O
of	O
mammalian	B-protein
runt	I-protein
products	I-protein
in	O
normal	O
and	O
leukemic	O
hematopoiesis	O
,	O
we	O
have	O
studied	O
their	O
pattern	O
of	O
expression	O
in	O
mouse	O
hematopoietic	O
tissues	O
in	O
the	O
adult	O
and	O
during	O
ontogeny	O
using	O
an	O
anti-runt	O
box	O
antiserum	O
.	O

In	O
the	O
adult	O
bone	O
marrow	O
,	O
we	O
found	O
expression	O
of	O
runt	O
polypeptides	O
in	O
differentiating	B-cell_type
myeloid	I-cell_type
cells	I-cell_type
and	O
in	O
B	B-cell_type
lymphocytes	I-cell_type
.	O

Within	O
the	O
erythroid	B-cell_type
lineage	I-cell_type
,	O
runt	O
expression	O
is	O
biphasic	O
,	O
clearly	O
present	O
in	O
the	O
erythroblasts	B-cell_type
of	O
early	O
blood	O
islands	O
and	O
of	O
the	O
fetal	O
liver	O
,	O
but	O
absent	O
in	O
the	O
adult	O
.	O

Biochemical	O
analysis	O
by	O
Western	O
blotting	O
of	O
fetal	B-cell_type
and	I-cell_type
adult	I-cell_type
hematopoietic	I-cell_type
populations	I-cell_type
shows	O
several	O
runt	B-protein
isoforms	I-protein
.	O

At	O
least	O
one	O
of	O
them	O
appears	O
to	O
be	O
myeloid	O
specific	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Lineage-	NULL
and	NULL
Stage-Specific	NULL
Expression	NULL
of	NULL
Runt	NULL
Box	NULL
Polypeptides	NULL
in	NULL
Primitive	NULL
and	NULL
Definitive	NULL
Hematopoiesis	NULL
By	NULL
Maria	NULL
Teresa	NULL
Corsetti	NULL
and	NULL
Franco	NULL
Calabi	NULL
Translocations	NULL
involving	NULL
the	NULL
human	NULL
CBFA2	NULL
locus	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
leukemia	NULL
.	NULL

This	NULL
gene	NULL
,	NULL
originally	NULL
named	NULL
AML1	NULL
,	NULL
is	NULL
a	NULL
human	NULL
homologue	NULL
of	NULL
the	NULL
Drosophila	NULL
gene	NULL
runt	NULL
that	NULL
controls	NULL
early	NULL
events	NULL
in	NULL
fly	NULL
embryogenesis	NULL
.	NULL

To	NULL
clarify	NULL
the	NULL
role	NULL
of	NULL
mammalian	NULL
runt	NULL
products	NULL
in	NULL
normal	NULL
and	NULL
leukemic	NULL
hematopoiesis	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
their	NULL
pattern	NULL
of	NULL
expression	NULL
in	NULL
mouse	NULL
hematopoietic	NULL
tissues	NULL
in	NULL
the	NULL
adult	NULL
and	NULL
during	NULL
ontogeny	NULL
using	NULL
an	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
.	NULL

In	NULL
the	NULL
adult	NULL
bone	NULL
marrow	NULL
,	NULL
we	NULL
found	NULL
expression	NULL
of	NULL
runt	NULL
polypeptides	NULL
in	NULL
differ	NULL
HE	NULL
runt	NULL
locus	NULL
of	NULL
Drosophila	NULL
melanogaster	NULL
controls	NULL
early	NULL
developmental	NULL
events	NULL
in	NULL
segmentation	NULL
,	NULL
sex	NULL
deter-mination	NULL
,	NULL
and	NULL
neurogenesis	NULL
.	NULL
``	NULL

The	NULL
first	NULL
mammalian	NULL
runt	NULL
homologue	NULL
was	NULL
identified	NULL
in	NULL
humans	NULL
as	NULL
the	NULL
locus	NULL
,	NULL
on	NULL
21q22	NULL
,	NULL
involved	NULL
in	NULL
the	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

*	NULL
``	NULL
Because	NULL
of	NULL
this	NULL
,	NULL
it	NULL
was	NULL
initially	NULL
named	NULL
AML1	NULL
.	NULL

Three	NULL
runt-like	NULL
loci	NULL
have	NULL
been	NULL
characterized	NULL
both	NULL
in	NULL
humans	NULL
and	NULL
in	NULL
mice	NULL
.	NULL
``	NULL

The	NULL
official	NULL
nomenclature	NULL
(	NULL
CBFAI-3	NULL
,	NULL
in	NULL
which	NULL
the	NULL
acronym	NULL
stands	NULL
for	NULL
Core	NULL
Binding	NULL
Factor	NULL
,	NULL
a	NULL
subunit	NULL
)	NULL
reflects	NULL
the	NULL
recognition	NULL
that	NULL
runt	NULL
products	NULL
bind	NULL
DNA	NULL
with	NULL
specificity	NULL
for	NULL
a	NULL
consensus	NULL
sequence	NULL
(	NULL
Pu/TACCPwCA'~	NULL
``	NULL
)	NULL
,	NULL
which	NULL
was	NULL
originally	NULL
identified	NULL
in	NULL
viral	NULL
enhancers	NULL
``	NULL
and	NULL
later	NULL
also	NULL
found	NULL
in	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
genes	NULL
.	NULL
'	NULL

''	NULL
*	NULL
``	NULL
``	NULL
The	NULL
DNA	NULL
binding	NULL
domain	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
coincide	NULL
with	NULL
an	NULL
approximately	NULL
120	NULL
amino	NULL
acid	NULL
sequence	NULL
that	NULL
is	NULL
conserved	NULL
among	NULL
all	NULL
known	NULL
runt	NULL
family	NULL
members	NULL
(	NULL
runt	NULL
box	NULL
)	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
At	NULL
least	NULL
the	NULL
CBFA	NULL
!	NULL

and	NULL
CBFA2	NULL
loci	NULL
give	NULL
rise	NULL
to	NULL
multiple	NULL
isoforms	NULL
because	NULL
of	NULL
alternative	NULL
splicing	NULL
.	NULL
``	NULL

Functional	NULL
studies	NULL
suggest	NULL
that	NULL
some	NULL
of	NULL
these	NULL
may	NULL
have	NULL
opposing	NULL
effects	NULL
on	NULL
the	NULL
transcription	NULL
of	NULL
test	NULL
target	NULL
genes	NULL
and	NULL
on	NULL
cell	NULL
differentiation	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
current	NULL
evidence	NULL
suggests	NULL
that	NULL
runt	NULL
products	NULL
make	NULL
up	NULL
a	NULL
complex	NULL
regulatory	NULL
system	NULL
that	NULL
controls	NULL
critical	NULL
events	NULL
in	NULL
differentiation	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
CBFA	NULL
genes	NULL
has	NULL
been	NULL
investigated	NULL
both	NULL
in	NULL
the	NULL
adult	NULL
and	NULL
in	NULL
the	NULL
fetus	NULL
at	NULL
the	NULL
mRNA	NULL
level	NULL
.	NULL
``	NULL

However	NULL
,	NULL
only	NULL
partial	NULL
data	NULL
are	NULL
available	NULL
for	NULL
the	NULL
hematopoietic	NULL
system	NULL
.	NULL

In	NULL
most	NULL
adult	NULL
vertebrates	NULL
,	NULL
hematopoiesis	NULL
occurs	NULL
largely	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
,	NULL
where	NULL
a	NULL
limited	NULL
pool	NULL
of	NULL
pluripotential	NULL
stem	NULL
cells	NULL
gives	NULL
rise	NULL
,	NULL
through	NULL
sequential	NULL
commitment	NULL
and	NULL
differentiation	NULL
steps	NULL
,	NULL
to	NULL
mature	NULL
blood	NULL
cells	NULL
of	NULL
the	NULL
different	NULL
lineages	NULL
:	NULL
erythrocytes	NULL
,	NULL
granulocytes	NULL
,	NULL
platelets	NULL
(	NULL
megakaryocytes	NULL
)	NULL
,	NULL
and	NULL
lymphocytes	NULL
.	NULL
``	NULL

This	NULL
adult	NULL
or	NULL
definitive	NULL
hematopoietic	NULL
phase	NULL
is	NULL
preceded	NULL
,	NULL
in	NULL
ontogeny	NULL
,	NULL
by	NULL
others	NULL
in	NULL
which	NULL
hematopoietic	NULL
stem	NULL
cell	NULL
activity	NULL
can	NULL
be	NULL
found	NULL
at	NULL
three	NULL
other	NULL
sites	NULL
:	NULL
the	NULL
yolk	NULL
sac	NULL
,	NULL
the	NULL
aorta-genital	NULL
ridge-mesonephros	NULL
(	NULL
AGM	NULL
)	NULL
region	NULL
,	NULL
and	NULL
the	NULL
fetal	NULL
liver	NULL
.	NULL
``	NULL

Significant	NULL
differences	NULL
are	NULL
known	NULL
to	NULL
exist	NULL
between	NULL
the	NULL
different	NULL
phases	NULL
.	NULL
``	NULL

Recently	NULL
,	NULL
by	NULL
generating	NULL
mouse	NULL
lines	NULL
functionally	NULL
deleted	NULL
in	NULL
the	NULL
CBFAZ	NULL
locus	NULL
,	NULL
a	NULL
requirement	NULL
has	NULL
been	NULL
postulated	NULL
for	NULL
this	NULL
locus	NULL
in	NULL
hematopoiesis	NULL
starting	NULL
from	NULL
the	NULL
fetal	NULL
liver	NULL
phase	NULL
.	NULL
``	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
hematopoietic	NULL
function	NULL
of	NULL
the	NULL
yolk	NULL
sac	NULL
was	NULL
apparently	NULL
unimpaired	NULL
in	NULL
these	NULL
lines	NULL
.	NULL

However	NULL
,	NULL
no	NULL
direct	NULL
evidence	NULL
is	NULL
available	NULL
regarding	NULL
the	NULL
expression	NULL
of	NULL
runt	NULL
polypeptides	NULL
within	NULL
hematopoietic	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
set	NULL
out	NULL
to	NULL
provide	NULL
such	NULL
evi-dence	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
we	NULL
aimed	NULL
to	NULL
address	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
the	NULL
characteristic	NULL
leukemic	NULL
phenotypes	NULL
associated	NULL
Blood	NULL
,	NULL
Vol	NULL
89	NULL
,	NULL
No	NULL
7	NULL
(	NULL
April	NULL
1	NULL
)	NULL
,	NULL
1997	NULL
;	NULL
pp	NULL
2359-2368	NULL
entiating	NULL
myeloid	NULL
cells	NULL
and	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

Within	NULL
the	NULL
erythroid	NULL
lineage	NULL
,	NULL
runt	NULL
expression	NULL
is	NULL
biphasic	NULL
,	NULL
clearly	NULL
present	NULL
in	NULL
the	NULL
erythroblasts	NULL
of	NULL
early	NULL
blood	NULL
islands	NULL
and	NULL
of	NULL
the	NULL
fetal	NULL
liver	NULL
,	NULL
but	NULL
absent	NULL
in	NULL
the	NULL
adult	NULL
.	NULL

Biochemical	NULL
analysis	NULL
by	NULL
Western	NULL
blotting	NULL
of	NULL
fetal	NULL
and	NULL
adult	NULL
hematopoietic	NULL
populations	NULL
shows	NULL
several	NULL
runt	NULL
isoforms	NULL
.	NULL

At	NULL
least	NULL
one	NULL
of	NULL
them	NULL
appears	NULL
to	NULL
be	NULL
myeloid	NULL
specific	NULL
.	NULL

©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

with	NULL
translocations	NULL
involving	NULL
the	NULL
human	NULL
CBFA2Z	NULL
locus	NULL
correlate	NULL
with	NULL
a	NULL
restricted	NULL
expression	NULL
of	NULL
normal	NULL
runt	NULL
products	NULL
to	NULL
specific	NULL
lineages	NULL
or	NULL
stages	NULL
of	NULL
hematopoietic	NULL
differentiation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Mice	NULL
and	NULL
embryos	NULL
.	NULL

TO	NULL
mice	NULL
were	NULL
used	NULL
as	NULL
a	NULL
source	NULL
of	NULL
embryos	NULL
.	NULL

Gestational	NULL
age	NULL
,	NULL
which	NULL
was	NULL
measured	NULL
in	NULL
days	NULL
post	NULL
coitum	NULL
(	NULL
dpc	NULL
)	NULL
,	NULL
was	NULL
calculated	NULL
from	NULL
midnight	NULL
of	NULL
the	NULL
mating	NULL
night	NULL
.	NULL

Pregnant	NULL
mice	NULL
were	NULL
killed	NULL
by	NULL
cervical	NULL
dislocation	NULL
.	NULL

Embryos	NULL
were	NULL
collected	NULL
in	NULL
cold	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
immediately	NULL
processed	NULL
.	NULL

The	NULL
7.5-day	NULL
embryos	NULL
were	NULL
embedded	NULL
without	NULL
removing	NULL
the	NULL
decidua	NULL
.	NULL

Fetal	NULL
livers	NULL
were	NULL
dissected	NULL
with	NULL
the	NULL
help	NULL
of	NULL
a	NULL
dissection	NULL
microscope	NULL
.	NULL

Normal	NULL
adult	NULL
tissues	NULL
were	NULL
obtained	NULL
from	NULL
TO	NULL
or	NULL
CD1	NULL
mice	NULL
.	NULL

Bone	NULL
marrow	NULL
was	NULL
obtained	NULL
by	NULL
flushing	NULL
the	NULL
femoral	NULL
and	NULL
tibial	NULL
shafts	NULL
with	NULL
cold	NULL
PBS	NULL
.	NULL

Expression	NULL
of	NULL
-	NULL
recombinant	NULL
-	NULL
proteins	NULL
.	NULL

|	NULL
Constructs	NULL
encoding	NULL
AML1	NULL
,	NULL
*	NULL
an	NULL
AML1/MTG8	NULL
in-frame	NULL
fusion	NULL
,	NULL
``	NULL
and	NULL
an	NULL
AML1/MTGS8	NULL
out-of-frame	NULL
fusion	NULL
``	NULL
were	NULL
assembled	NULL
in	NULL
eukaryotic	NULL
expression	NULL
vectors	NULL
or	NULL
pBABE	NULL
Neo*	NULL
``	NULL
from	NULL
genomic	NULL
and	NULL
cDNA	NULL
fragments	NULL
and	NULL
verified	NULL
by	NULL
sequencing	NULL
(	NULL
F.	NULL
Calabi	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

COS-7	NULL
cells	NULL
``	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
diethyl	NULL
aminoethyl-dextran/chlo-roquine	NULL
procedure	NULL
.	NULL
``	NULL

Cells	NULL
were	NULL
harvested	NULL
48	NULL
hours	NULL
after	NULL
transfection	NULL
.	NULL

A	NULL
cDNA	NULL
fragment	NULL
encoding	NULL
amino	NULL
acids	NULL
51	NULL
to	NULL
128	NULL
of	NULL
human	NULL
AML1*	NULL
was	NULL
joined	NULL
in	NULL
frame	NULL
to	NULL
the	NULL
glutathione-S-transferase	NULL
(	NULL
GST	NULL
)	NULL
coding	NULL
sequence	NULL
in	NULL
the	NULL
expression	NULL
vector	NULL
pGEX-2T	NULL
(	NULL
Pharmacia	NULL
LKB	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Escherichia	NULL
coli	NULL
TG1	NULL
cells	NULL
harboring	NULL
the	NULL
construct	NULL
were	NULL
grown	NULL
in	NULL
SOB*/ampicillin	NULL
medium	NULL
to	NULL
an	NULL
ODss	NULL
,	NULL
of	NULL
0.5	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
isopropyl-0-p-thiogalactoside	NULL
(	NULL
IPTG	NULL
;	NULL
1	NULL
mmol/L	NULL
final	NULL
concentration	NULL
)	NULL
.	NULL

After	NULL
a	NULL
further	NULL
4.5	NULL
hours	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
lysed	NULL
essentially	NULL
as	NULL
described	NULL
.	NULL
``	NULL

A	NULL
significant	NULL
fraction	NULL
of	NULL
the	NULL
recombinant	NULL
GST/runt	NULL
box	NULL
polypeptide	NULL
was	NULL
found	NULL
to	NULL
be	NULL
soluble	NULL
in	NULL
the	NULL
detergent	NULL
lysate	NULL
and	NULL
directly	NULL
purified	NULL
by	NULL
binding	NULL
to	NULL
glutathi-one-agarose	NULL
(	NULL
Sigma	NULL
,	NULL
Poole	NULL
,	NULL
Dorset	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
elution	NULL
with	NULL
5	NULL
mmol/L	NULL
From	NULL
the	NULL
Developmental	NULL
Biology	NULL
Unit	NULL
,	NULL
Division	NULL
of	NULL
Cell	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Institute	NULL
of	NULL
Child	NULL
Health	NULL
,	NULL
London	NULL
,	NULL
UK	NULL
.	NULL

Submitted	NULL
January	NULL
22	NULL
,	NULL
1996	NULL
;	NULL
accepted	NULL
November	NULL
7	NULL
,	NULL
1996	NULL
.	NULL

Supported	NULL
by	NULL
MRC	NULL
Programme	NULL
Grant	NULL
No	NULL
.	NULL

PG9311737	NULL
.	NULL

M.T.C	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
an	NULL
EMBO	NULL
long-term	NULL
fellowship	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Franco	NULL
Calabi	NULL
,	NULL
MD	NULL
,	NULL
Developmental	NULL
Biology	NULL
Unit	NULL
,	NULL
Division	NULL
of	NULL
Cell	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Institute	NULL
of	NULL
Child	NULL
Health	NULL
,	NULL
30	NULL
Guilford	NULL
St	NULL
,	NULL
London	NULL
WCIN	NULL
1IEH	NULL
,	NULL
UK	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/97/8907-0036	NULL
$	NULL
3.00/0	NULL
2359	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2360	NULL
reduced	NULL
glutathione	NULL
(	NULL
GSH	NULL
)	NULL
in	NULL
0.1	NULL
mol/L	NULL
sodium	NULL
phosphate	NULL
buffer	NULL
,	NULL
pH	NULL
8	NULL
.	NULL

Preparation	NULL
of	NULL
the	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
.	NULL

A	NULL
New	NULL
Zealand	NULL
rabbit	NULL
was	NULL
immunized	NULL
with	NULL
approximately	NULL
250	NULL
ug	NULL
recombinant	NULL
GST/	NULL
runt	NULL
box	NULL
polypeptide	NULL
by	NULL
subcutaneous	NULL
injection	NULL
in	NULL
complete	NULL
Freund	NULL
's	NULL
adjuvant	NULL
.	NULL

Two	NULL
further	NULL
injections	NULL
were	NULL
administered	NULL
in	NULL
incomplete	NULL
Freund	NULL
's	NULL
adjuvant	NULL
at	NULL
10-day	NULL
intervals	NULL
.	NULL

After	NULL
5	NULL
months	NULL
of	NULL
rest	NULL
,	NULL
the	NULL
rabbit	NULL
was	NULL
boosted	NULL
by	NULL
a	NULL
subcutaneous	NULL
injection	NULL
of	NULL
approximately	NULL
10	NULL
ug	NULL
purified	NULL
runt	NULL
box	NULL
fragment	NULL
.	NULL

This	NULL
was	NULL
prepared	NULL
from	NULL
the	NULL
affinity-purified	NULL
GST/runt	NULL
box	NULL
polypeptide	NULL
by	NULL
digestion	NULL
with	NULL
thrombin	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
preparative	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacryl-amide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
.	NULL

The	NULL
antiserum	NULL
obtained	NULL
from	NULL
the	NULL
boosted	NULL
rabbit	NULL
was	NULL
first	NULL
depleted	NULL
of	NULL
antibodies	NULL
reactive	NULL
with	NULL
GST	NULL
and	NULL
bacterial	NULL
antigens	NULL
by	NULL
passing	NULL
it	NULL
through	NULL
an	NULL
Affi-Gel	NULL
10	NULL
column	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
coupled	NULL
to	NULL
total	NULL
cellular	NULL
proteins	NULL
(	NULL
70	NULL
OD	NULL
;	NULL
s	NULL
,	NULL
U/mL	NULL
gel	NULL
)	NULL
from	NULL
an	NULL
IPTG-induced	NULL
bacterial	NULL
culture	NULL
harboring	NULL
the	NULL
pGEX-2T	NULL
vector	NULL
.	NULL

Depletion	NULL
was	NULL
verified	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

The	NULL
anti-runt	NULL
box	NULL
antibodies	NULL
were	NULL
then	NULL
further	NULL
purified	NULL
by	NULL
affinity	NULL
chromatography	NULL
on	NULL
an	NULL
Affi-Gel	NULL
10	NULL
column	NULL
coupled	NULL
to	NULL
affinity-purified	NULL
GST/runt	NULL
box	NULL
polypeptide	NULL
(	NULL
4	NULL
mg/mL	NULL
gel	NULL
)	NULL
.	NULL

Bound	NULL
antibodies	NULL
were	NULL
eluted	NULL
first	NULL
with	NULL
0.1	NULL
mol/L	NULL
glycine	NULL
,	NULL
10	NULL
%	NULL
dioxan	NULL
,	NULL
pH	NULL
2.5	NULL
,	NULL
followed	NULL
by	NULL
0.1	NULL
mol/L	NULL
diethylamine	NULL
,	NULL
pH	NULL
11.5.5	NULL
``	NULL
Acid-	NULL
and	NULL
alkali-eluted	NULL
fractions	NULL
were	NULL
dialyzed	NULL
against	NULL
PBS	NULL
,	NULL
pH	NULL
7.2	NULL
;	NULL
pooled	NULL
;	NULL
and	NULL
concentrated	NULL
on	NULL
Centricon	NULL
30	NULL
(	NULL
Amicon	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Antibodies	NULL
.	NULL

The	NULL
following	NULL
rat	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
MoAbs	NULL
)	NULL
were	NULL
used	NULL
:	NULL
3C1	NULL
,	NULL
anti-c-kit	NULL
,	NULL
or	NULL
CD117*	NULL
(	NULL
Pharmingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
RB6-8C5	NULL
,	NULL
anti-Gr-1*	NULL
(	NULL
Pharmingen	NULL
)	NULL
;	NULL
M1/70	NULL
,	NULL
anti-Mac-1	NULL
,	NULL
or	NULL
CD11b	NULL
``	NULL
(	NULL
Serotec	NULL
,	NULL
Oxford	NULL
,	NULL
UK	NULL
)	NULL
;	NULL
TER-119	NULL
,	NULL
anti-mouse	NULL
erythroid	NULL
cells	NULL
``	NULL
(	NULL
Pharmingen	NULL
)	NULL
;	NULL
and	NULL
RA3-6B2	NULL
,	NULL
anti-CD45R	NULL
,	NULL
or	NULL
B220°	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

A	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
polyclonal	NULL
rabbit	NULL
anti-mouse	NULL
serum	NULL
(	NULL
Dako	NULL
,	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
)	NULL
was	NULL
used	NULL
to	NULL
identify	NULL
B	NULL
cells	NULL
.	NULL

Mouse	NULL
bone	NULL
marrow	NULL
cell	NULL
separation	NULL
.	NULL

|	NULL
The	NULL
separations	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
VarioMacs	NULL
System	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
,	NULL
Bergisch-Glad-back	NULL
,	NULL
Germany	NULL
)	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
(	NULL
up	NULL
to	NULL
5	NULL
x	NULL
10*/mL	NULL
,	NULL
in	NULL
PBS	NULL
,	NULL
pH	NULL
7.2	NULL
,	NULL
containing	NULL
1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
5	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
and	NULL
0.01	NULL
%	NULL
azide	NULL
)	NULL
were	NULL
labeled	NULL
with	NULL
the	NULL
rat	NULL
primary	NULL
antibody	NULL
(	NULL
TER-119	NULL
or	NULL
FITC-coupled	NULL
Gr-1	NULL
and	NULL
CD45R	NULL
,	NULL
0.5	NULL
to	NULL
1	NULL
ug/10°	NULL
cells	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
on	NULL
ice	NULL
,	NULL
washed	NULL
once	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
goat	NULL
anti-rat	NULL
Ig	NULL
coupled	NULL
to	NULL
Microbeads	NULL
for	NULL
20	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
passed	NULL
over	NULL
an	NULL
AZ	NULL
column	NULL
placed	NULL
in	NULL
a	NULL
VarioMACS	NULL
separator	NULL
.	NULL

Purity	NULL
of	NULL
the	NULL
sorted	NULL
cells	NULL
was	NULL
checked	NULL
using	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
TER-119	NULL
,	NULL
eluted	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
FITC-conjugated	NULL
mouse	NULL
anti-rat	NULL
Ig	NULL
(	NULL
Jackson	NULL
,	NULL
West	NULL
Grove	NULL
,	NULL
PA	NULL
)	NULL
before	NULL
FACS	NULL
analysis	NULL
.	NULL

After	NULL
a	NULL
single	NULL
passage	NULL
through	NULL
the	NULL
magnetic	NULL
field	NULL
,	NULL
Gr-1	NULL
and	NULL
CD45R	NULL
positively	NULL
selected	NULL
populations	NULL
were	NULL
usually	NULL
found	NULL
to	NULL
be	NULL
about	NULL
90	NULL
%	NULL
pure	NULL
.	NULL

However	NULL
,	NULL
TER-119	NULL
cells	NULL
were	NULL
only	NULL
enriched	NULL
to	NULL
50	NULL
%	NULL
to	NULL
60	NULL
%	NULL
because	NULL
of	NULL
cell	NULL
clumping	NULL
occurring	NULL
on	NULL
the	NULL
column	NULL
and	NULL
causing	NULL
nonspecific	NULL
trapping	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
most	NULL
cases	NULL
,	NULL
the	NULL
enriched	NULL
TER-119	NULL
population	NULL
was	NULL
dispersed	NULL
by	NULL
pipetting	NULL
as	NULL
carefully	NULL
as	NULL
possible	NULL
and	NULL
reapplied	NULL
to	NULL
the	NULL
column	NULL
.	NULL

The	NULL
final	NULL
purity	NULL
was	NULL
60	NULL
%	NULL
to	NULL
75	NULL
%	NULL
.	NULL

Immunohistochemistry	NULL
.	NULL

-	NULL
Cytospin	NULL
preparations	NULL
were	NULL
fixed	NULL
for	NULL
5	NULL
minutes	NULL
in	NULL
4	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
PBS	NULL
,	NULL
pH	NULL
7.2	NULL
;	NULL
washed	NULL
for	NULL
2	NULL
minutes	NULL
in	NULL
PBS/0.5	NULL
%	NULL
Triton	NULL
X-100	NULL
;	NULL
and	NULL
incubated	NULL
in	NULL
PBS/10	NULL
%	NULL
goat	NULL
serum/0.1	NULL
%	NULL
azide	NULL
(	NULL
blocking	NULL
solution	NULL
)	NULL
.	NULL

They	NULL
were	NULL
then	NULL
sequentially	NULL
incubated	NULL
with	NULL
(	NULL
1	NULL
)	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
(	NULL
~10	NULL
pg/mL	NULL
.	NULL
)	NULL

in	NULL
blocking	NULL
solution	NULL
for	NULL
1	NULL
hour	NULL
to	NULL
overnight	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
(	NULL
2	NULL
)	NULL
biotinylated	NULL
goat	NULL
anti-rabbit	NULL
antiserum	NULL
(	NULL
Vector	NULL
,	NULL
Burlingame	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
at	NULL
least	NULL
1	NULL
hour	NULL
,	NULL
and	NULL
(	NULL
3	NULL
)	NULL
FITC-conjugated	NULL
goat	NULL
anti-biotin	NULL
antiserum	NULL
(	NULL
Vector	NULL
)	NULL
or	NULL
with	NULL
R-Phycoerythrin-ExtraAvidin	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Double	NULL
immunolabeling	NULL
on	NULL
single-cell	NULL
suspensions	NULL
was	NULL
performed	NULL
as	NULL
follows	NULL
.	NULL

After	NULL
5	NULL
minutes	NULL
of	NULL
preincubation	NULL
on	NULL
ice	NULL
in	NULL
blocking	NULL
solution	NULL
containing	NULL
0.02	NULL
%	NULL
azide	NULL
,	NULL
the	NULL
anti-cell	NULL
surface	NULL
antigen	NULL
rat	NULL
CORSETT	NULL
!	NULL

AND	NULL
CALABI	NULL
MoAb	NULL
was	NULL
added	NULL
(	NULL
2	NULL
ug/10°	NULL
cells	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
twice	NULL
,	NULL
resuspended	NULL
in	NULL
blocking	NULL
solution	NULL
,	NULL
and	NULL
cytospun	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
processed	NULL
as	NULL
above	NULL
,	NULL
adding	NULL
an	NULL
FITC-conjugated	NULL
mouse	NULL
anti-rat	NULL
serum	NULL
(	NULL
Jackson	NULL
)	NULL
to	NULL
samples	NULL
treated	NULL
with	NULL
unlabeled	NULL
TER-119	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
the	NULL
purified	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
was	NULL
preincubated	NULL
for	NULL
at	NULL
least	NULL
2	NULL
hours	NULL
at	NULL
4°C	NULL
with	NULL
extracts	NULL
from	NULL
bacteria	NULL
expressing	NULL
either	NULL
the	NULL
GST/runt	NULL
box	NULL
or	NULL
the	NULL
GST	NULL
proteins	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
GST/runt	NULL
box	NULL
extract	NULL
required	NULL
for	NULL
complete	NULL
inhibition	NULL
of	NULL
the	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
at	NULL
the	NULL
working	NULL
dilution	NULL
was	NULL
determined	NULL
empirically	NULL
by	NULL
titration	NULL
.	NULL

Approximately	NULL
50	NULL
4L	NULL
of	NULL
antiserum	NULL
,	NULL
ie	NULL
,	NULL
the	NULL
amount	NULL
generally	NULL
used	NULL
per	NULL
one	NULL
slide	NULL
,	NULL
could	NULL
usually	NULL
be	NULL
completely	NULL
inhibited	NULL
by	NULL
the	NULL
extract	NULL
from	NULL
1	NULL
mL	NULL
.	NULL

of	NULL
bacterial	NULL
culture	NULL
.	NULL

In	NULL
every	NULL
experiment	NULL
,	NULL
parallel	NULL
samples	NULL
were	NULL
stained	NULL
with	NULL
rabbit	NULL
preimmune	NULL
serum	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

Slides	NULL
were	NULL
mounted	NULL
in	NULL
an	NULL
antifade	NULL
medium	NULL
(	NULL
Vector	NULL
)	NULL
and	NULL
examined	NULL
using	NULL
a	NULL
Zeiss	NULL
Axioskop	NULL
fluorescence	NULL
microscope	NULL
(	NULL
Carl	NULL
Zeiss	NULL
,	NULL
Jena	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Images	NULL
were	NULL
captured	NULL
by	NULL
a	NULL
Photometrics	NULL
CCD	NULL
camera	NULL
(	NULL
Photometrics	NULL
,	NULL
Tucson	NULL
,	NULL
AZ	NULL
)	NULL
coupled	NULL
to	NULL
a	NULL
Macintosh	NULL
Quadra	NULL
computer	NULL
(	NULL
Apple	NULL
Computers	NULL
,	NULL
Cupertino	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Image	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
Smartcapture	NULL
Software	NULL
(	NULL
Digital	NULL
Scientific	NULL
,	NULL
Cam-bridge	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Paraffin	NULL
sections	NULL
were	NULL
prepared	NULL
for	NULL
staining	NULL
according	NULL
to	NULL
published	NULL
procedures*	NULL
with	NULL
minor	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
whole	NULL
embryos	NULL
and	NULL
dissected	NULL
organs	NULL
were	NULL
frozen	NULL
by	NULL
immersion	NULL
in	NULL
iso-pentane	NULL
precooled	NULL
to	NULL
freezing	NULL
point	NULL
,	NULL
transferred	NULL
to	NULL
precooled	NULL
ethanol	NULL
(	NULL
-70°C	NULL
)	NULL
,	NULL
and	NULL
left	NULL
for	NULL
3	NULL
days	NULL
.	NULL

After	NULL
this	NULL
,	NULL
cold	NULL
ethanol	NULL
was	NULL
replaced	NULL
every	NULL
2	NULL
days	NULL
(	NULL
usually	NULL
3	NULL
times	NULL
)	NULL
to	NULL
complete	NULL
dehydration	NULL
.	NULL

Specimens	NULL
were	NULL
subsequently	NULL
equilibrated	NULL
to	NULL
room	NULL
temperature	NULL
and	NULL
embedded	NULL
in	NULL
paraffin	NULL
wax	NULL
.	NULL

Microtome	NULL
sections	NULL
(	NULL
8-pm	NULL
thick	NULL
)	NULL
were	NULL
dewaxed	NULL
in	NULL
xylene	NULL
(	NULL
3	NULL
changes	NULL
of	NULL
2	NULL
minutes	NULL
each	NULL
)	NULL
,	NULL
rehydrated	NULL
in	NULL
graded	NULL
ethanol	NULL
baths	NULL
,	NULL
incubated	NULL
in	NULL
blocking	NULL
solution	NULL
,	NULL
and	NULL
processed	NULL
as	NULL
described	NULL
above	NULL
,	NULL
except	NULL
that	NULL
the	NULL
fluorescent	NULL
reagent	NULL
was	NULL
substituted	NULL
with	NULL
preformed	NULL
streptavidin-biotinylated	NULL
horseradish	NULL
peroxidase	NULL
complex	NULL
(	NULL
Dako	NULL
)	NULL
.	NULL

Bound	NULL
peroxidase	NULL
was	NULL
detected	NULL
using	NULL
di-amino-benzidine	NULL
(	NULL
DAB	NULL
)	NULL
/NiC	NULL
]	NULL
;	NULL
as	NULL
sub-strate	NULL
.	NULL

Western	NULL
blotting	NULL
.	NULL

-	NULL
Cells	NULL
were	NULL
lysed	NULL
in	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
``	NULL
and	NULL
sonicated	NULL
to	NULL
shear	NULL
DNA	NULL
;	NULL
aliquots	NULL
(	NULL
10	NULL
'	NULL
cells	NULL
)	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
on	NULL
a	NULL
9	NULL
%	NULL
to	NULL
18	NULL
%	NULL
gradient	NULL
gel	NULL
and	NULL
blotted	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
filter	NULL
(	NULL
Schleicher	NULL
and	NULL
Schiiell	NULL
,	NULL
Dassel	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
blocked	NULL
with	NULL
2.5	NULL
%	NULL
nonfat	NULL
,	NULL
dry	NULL
milk	NULL
powder	NULL
in	NULL
PBS	NULL
before	NULL
incubation	NULL
for	NULL
3	NULL
hours	NULL
with	NULL
purified	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
diluted	NULL
in	NULL
PBS	NULL
containing	NULL
2	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
.	NULL

After	NULL
washing	NULL
in	NULL
PBS/	NULL
0.5	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
developed	NULL
with	NULL
1	NULL
4Ci/10	NULL
mL	NULL
'	NULL
``	NULL
L-protein	NULL
A	NULL
(	NULL
>	NULL
30	NULL
mCi/mg	NULL
;	NULL
Amersham	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
UK	NULL
)	NULL
in	NULL
PBS/0.5	NULL
%	NULL
Tween	NULL
20	NULL
.	NULL

RESULTS	NULL
Production	NULL
of	NULL
an	NULL
antiserum	NULL
against	NULL
runt	NULL
box	NULL
polypeptides	NULL
.	NULL

A	NULL
polypeptide	NULL
corresponding	NULL
to	NULL
amino	NULL
acids	NULL
51	NULL
to	NULL
128	NULL
in	NULL
the	NULL
predicted	NULL
AML1	NULL
sequence*	NULL
(	NULL
ie	NULL
,	NULL
the	NULL
first	NULL
78	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
runt	NULL
box	NULL
)	NULL
was	NULL
expressed	NULL
in	NULL
E	NULL
coli	NULL
as	NULL
a	NULL
fusion	NULL
to	NULL
GST	NULL
.	NULL

After	NULL
affinity	NULL
purification	NULL
on	NULL
glutathione-agarose	NULL
,	NULL
it	NULL
was	NULL
used	NULL
to	NULL
immunize	NULL
a	NULL
rabbit	NULL
.	NULL

Initial	NULL
testing	NULL
of	NULL
the	NULL
raw	NULL
antiserum	NULL
showed	NULL
reactivity	NULL
against	NULL
cellular	NULL
components	NULL
that	NULL
was	NULL
not	NULL
blocked	NULL
by	NULL
the	NULL
GST/runt	NULL
box	NULL
polypeptide	NULL
.	NULL

The	NULL
antiserum	NULL
was	NULL
then	NULL
affinity	NULL
purified	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
to	NULL
yield	NULL
an	NULL
operationally	NULL
specific	NULL
reagent	NULL
,	NULL
as	NULL
tested	NULL
on	NULL
Western	NULL
blots	NULL
of	NULL
expressing	NULL
bacterial	NULL
lysates	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
a	NULL
further	NULL
stringent	NULL
specificity	NULL
criterion	NULL
,	NULL
in	NULL
most	NULL
of	NULL
our	NULL
immunostaining	NULL
experiments	NULL
we	NULL
have	NULL
made	NULL
use	NULL
,	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
,	NULL
of	NULL
purified	NULL
antiserum	NULL
blocked	NULL
by	NULL
preincuba-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RUNT	NULL
BOX	NULL
POLYPEPTIDES	NULL
IN	NULL
HEMATOPOIESIS	NULL
A	NULL
pse-rus	NULL
[	NULL
Rei	NULL
|	NULL
pBEH-RM	NULL
pBN-TG2	NULL
B	NULL
Fig	NULL
1	NULL
.	NULL

Reactivity	NULL
of	NULL
the	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
against	NULL
runt	NULL
box	NULL
polypeptides	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
diagram	NULL
of	NULL
the	NULL
different	NULL
polypeptides	NULL
tested	NULL
.	NULL

The	NULL
runt	NULL
box	NULL
is	NULL
in	NULL
black	NULL
;	NULL
the	NULL
chromosome	NULL
8	NULL
sequence	NULL
in	NULL
pBEH/	NULL
RM	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
hatched	NULL
box	NULL
;	NULL
a	NULL
short	NULL
sequence	NULL
of	NULL
chromosome	NULL
8	NULL
origin	NULL
is	NULL
also	NULL
present	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
runt	NULL
box	NULL
in	NULL
plamid	NULL
pBN-TG2	NULL
.	NULL

Numbers	NULL
refer	NULL
to	NULL
amino	NULL
acids	NULL
.	NULL

The	NULL
predicted	NULL
molecular	NULL
weight	NULL
is	NULL
on	NULL
the	NULL
right	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blotting	NULL
analysis	NULL
of	NULL
COS-7	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
plasmids	NULL
encoding	NULL
the	NULL
described	NULL
runt	NULL
box	NULL
polypeptides	NULL
.	NULL

``	NULL
pre	NULL
``	NULL
and	NULL
``	NULL
anti-rbox	NULL
``	NULL
refer	NULL
to	NULL
the	NULL
use	NULL
of	NULL
preimmune	NULL
serum	NULL
or	NULL
of	NULL
affinity-purified	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
,	NULL
respec-tively	NULL
.	NULL

As	NULL
a	NULL
further	NULL
specificity	NULL
check	NULL
,	NULL
the	NULL
pBEH-RMS	NULL
lane	NULL
was	NULL
split	NULL
into	NULL
two	NULL
and	NULL
probed	NULL
with	NULL
purified	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
either	NULL
mock-depleted	NULL
(	NULL
by	NULL
preincubation	NULL
with	NULL
matrix-bound	NULL
GST	NULL
,	NULL
``	NULL
-	NULL
rbox	NULL
``	NULL
``	NULL
)	NULL
or	NULL
depleted	NULL
of	NULL
anti-GST	NULL
/runt	NULL
box	NULL
reactivity	NULL
(	NULL
by	NULL
preincubation	NULL
with	NULL
matrix-bound	NULL
GST/runt	NULL
box	NULL
,	NULL
``	NULL
+	NULL
rbox	NULL
``	NULL
}	NULL
.	NULL

mock	NULL
,	NULL
mock-transfected	NULL
COS	NULL
cells	NULL
.	NULL

The	NULL
three	NULL
leftmost	NULL
lanes	NULL
were	NULL
exposed	NULL
for	NULL
18	NULL
hours	NULL
,	NULL
the	NULL
others	NULL
for	NULL
3	NULL
days	NULL
.	NULL

tion	NULL
with	NULL
a	NULL
bacterial	NULL
lysate	NULL
expressing	NULL
the	NULL
GST/runt	NULL
box	NULL
polypeptide	NULL
.	NULL

This	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
signal	NULL
given	NULL
by	NULL
the	NULL
same	NULL
antiserum	NULL
preincubated	NULL
with	NULL
a	NULL
bacterial	NULL
lysate	NULL
expressing	NULL
a	NULL
comparable	NULL
amount	NULL
of	NULL
GST	NULL
alone	NULL
.	NULL

We	NULL
are	NULL
therefore	NULL
highly	NULL
confident	NULL
of	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
staining	NULL
observed	NULL
for	NULL
runt	NULL
polypeptides	NULL
.	NULL

The	NULL
reactivity	NULL
of	NULL
the	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
was	NULL
verified	NULL
by	NULL
Western	NULL
blotting	NULL
analysis	NULL
of	NULL
a	NULL
panel	NULL
of	NULL
COS-7	NULL
cells	NULL
expressing	NULL
three	NULL
different	NULL
runt	NULL
box-containing	NULL
polypeptides	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
:	NULL
a	NULL
30-kD	NULL
polypeptide	NULL
corresponding	NULL
to	NULL
AML1*	NULL
and	NULL
encoded	NULL
by	NULL
the	NULL
pBEH-RMS	NULL
plasmid	NULL
;	NULL
an	NULL
84-kD	NULL
polypeptide	NULL
corresponding	NULL
to	NULL
an	NULL
in-frame	NULL
AML1/MTG8	NULL
fusion	NULL
``	NULL
and	NULL
encoded	NULL
by	NULL
the	NULL
pBEH-RM	NULL
plasmid	NULL
;	NULL
and	NULL
a	NULL
19.5-kD	NULL
polypeptide	NULL
corresponding	NULL
to	NULL
an	NULL
out-of-frame	NULL
AML1/MTG	NULL
$	NULL
8	NULL
fusion	NULL
``	NULL
and	NULL
encoded	NULL
by	NULL
the	NULL
pBN-TG2	NULL
plasmid	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
the	NULL
major	NULL
detected	NULL
species	NULL
migrated	NULL
at	NULL
or	NULL
very	NULL
close	NULL
to	NULL
the	NULL
predicted	NULL
molecular	NULL
weight	NULL
.	NULL

1	NULL
249	NULL
30	NULL
kDa	NULL
ESI	NULL
]	NULL
@	NULL
1	NULL
180	NULL
[	NULL
FB	NULL
|	NULL
1	NULL
»	NULL
s	NULL
kDa	NULL
z	NULL
Se	NULL
l	NULL
-at	NULL
94	NULL
-	NULL
<	NULL
67	NULL
<	NULL
<	NULL
43	NULL
<	NULL
a	NULL
»	NULL
-	NULL
30	NULL
;	NULL
-l	NULL
20	NULL
'	NULL
pre	NULL
l	NULL
anti-rbox	NULL
'	NULL
Expression	NULL
of	NULL
runt	NULL
box	NULL
polypeptides	NULL
in	NULL
adult	NULL
bone	NULL
marrow	NULL
.	NULL

In	NULL
our	NULL
analysis	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
runt	NULL
box	NULL
polypeptides	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
we	NULL
focused	NULL
on	NULL
the	NULL
mouse	NULL
to	NULL
be	NULL
able	NULL
to	NULL
study	NULL
more	NULL
easily	NULL
both	NULL
the	NULL
adult	NULL
and	NULL
the	NULL
embryonic/fetal	NULL
stages	NULL
.	NULL

First	NULL
of	NULL
all	NULL
,	NULL
expression	NULL
in	NULL
adult	NULL
bone	NULL
marrow	NULL
was	NULL
investigated	NULL
on	NULL
cytospin	NULL
preparations	NULL
.	NULL

Most	NULL
cells	NULL
were	NULL
found	NULL
positive	NULL
for	NULL
runt	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
,	NULL
ranging	NULL
from	NULL
large	NULL
blasts	NULL
to	NULL
maturing	NULL
granulocytes	NULL
.	NULL

A	NULL
clear	NULL
positive	NULL
signal	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

It	NULL
was	NULL
somewhat	NULL
stronger	NULL
and	NULL
more	NULL
homogenous	NULL
in	NULL
the	NULL
larger	NULL
,	NULL
more	NULL
immature	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
lineage	NULL
of	NULL
runt-expressing	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
double	NULL
staining	NULL
with	NULL
lineage-specific	NULL
markers	NULL
.	NULL

Gr-1	NULL
and	NULL
Mac-1	NULL
were	NULL
used	NULL
for	NULL
myelomonocytic	NULL
elements	NULL
,	NULL
the	NULL
former	NULL
being	NULL
specific	NULL
for	NULL
the	NULL
granulocytic	NULL
lineage	NULL
,	NULL
whereas	NULL
the	NULL
latter	NULL
is	NULL
shared	NULL
by	NULL
granulocytes	NULL
and	NULL
monocytes	NULL
;	NULL
TER-119	NULL
for	NULL
erythroid	NULL
cells	NULL
;	NULL
and	NULL
Ig	NULL
for	NULL
B	NULL
cells	NULL
.	NULL

Essentially	NULL
all	NULL
Gr-1*	NULL
cells	NULL
express	NULL
runt	NULL
(	NULL
Fig	NULL
3A	NULL
)	NULL
.	NULL

In	NULL
preparations	NULL
developed	NULL
with	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2362	NULL
anti-rbox	NULL
CORSETT	NULL
!	NULL

AND	NULL
CALABI	NULL
anti-rbox	NULL
+	NULL
GST	NULL
a	NULL
peroxidase-conjugated	NULL
anti-rabbit	NULL
antiserum	NULL
and	NULL
counter-stained	NULL
with	NULL
Mayer	NULL
hemalum	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
the	NULL
smaller	NULL
cells	NULL
with	NULL
the	NULL
doughnut-shaped	NULL
nucleus	NULL
characteristic	NULL
of	NULL
mature	NULL
granulocytes	NULL
appear	NULL
to	NULL
be	NULL
less	NULL
positive	NULL
than	NULL
the	NULL
larger	NULL
,	NULL
more	NULL
immature	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Erythroid	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
identified	NULL
by	NULL
the	NULL
TER-119	NULL
antibody	NULL
,	NULL
do	NULL
not	NULL
show	NULL
a	NULL
clear	NULL
reactivity	NULL
;	NULL
some	NULL
dubious	NULL
spots	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
only	NULL
about	NULL
30	NULL
%	NULL
to	NULL
50	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
(	NULL
Fig	NULL
3C	NULL
)	NULL
.	NULL

B-lineage	NULL
cells	NULL
(	NULL
Ig	NULL
*	NULL
)	NULL
are	NULL
uniformly	NULL
positive	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
.	NULL

The	NULL
c-kit	NULL
receptor	NULL
is	NULL
helpful	NULL
in	NULL
defining	NULL
an	NULL
earlier	NULL
differentiation	NULL
stage	NULL
than	NULL
lineage	NULL
markers	NULL
,	NULL
because	NULL
approximately	NULL
50	NULL
%	NULL
of	NULL
the	NULL
positive	NULL
cells	NULL
are	NULL
negative	NULL
for	NULL
lineage	NULL
markers	NULL
.	NULL

About	NULL
70	NULL
%	NULL
of	NULL
the	NULL
c-kit-bearing	NULL
cells	NULL
are	NULL
runt-positive	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
runt	NULL
expression	NULL
is	NULL
also	NULL
found	NULL
in	NULL
some	NULL
precursor	NULL
cells	NULL
,	NULL
ie	NULL
,	NULL
before	NULL
terminal	NULL
differentiation	NULL
.	NULL

Because	NULL
monocytes	NULL
represent	NULL
only	NULL
a	NULL
minor	NULL
fraction	NULL
of	NULL
bone	NULL
marrow	NULL
cells	NULL
(	NULL
~2	NULL
%	NULL
)	NULL
,	NULL
expression	NULL
of	NULL
runt	NULL
in	NULL
the	NULL
mono-cytic	NULL
lineage	NULL
was	NULL
investigated	NULL
on	NULL
a	NULL
nearly	NULL
pure	NULL
population	NULL
of	NULL
residential	NULL
peritoneal	NULL
macrophages	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
found	NULL
to	NULL
overlap	NULL
completely	NULL
with	NULL
that	NULL
of	NULL
Mac-1	NULL
(	NULL
correspond-ing	NULL
to	NULL
70	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
)	NULL
.	NULL

The	NULL
megakaryocytic	NULL
lineage	NULL
was	NULL
not	NULL
studied	NULL
in	NULL
detail	NULL
.	NULL

However	NULL
,	NULL
the	NULL
large	NULL
hyperdiploid	NULL
megakaryocytes	NULL
,	NULL
which	NULL
are	NULL
easily	NULL
recognizable	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
,	NULL
are	NULL
runt-negative	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
runt	NULL
box	NULL
polypeptides	NULL
in	NULL
embryonic	NULL
hematopoiesis	NULL
.	NULL

-	NULL
We	NULL
next	NULL
moved	NULL
to	NULL
analyze	NULL
runt	NULL
expression	NULL
in	NULL
early	NULL
hematopoiesis	NULL
.	NULL

The	NULL
first	NULL
time	NULL
point	NULL
examined	NULL
was	NULL
at	NULL
7.5	NULL
dpc	NULL
.	NULL

At	NULL
this	NULL
time	NULL
,	NULL
blood	NULL
islands	NULL
begin	NULL
to	NULL
form	NULL
in	NULL
the	NULL
mesoderm	NULL
of	NULL
the	NULL
yolk	NULL
sac	NULL
and	NULL
erythroblasts	NULL
can	NULL
be	NULL
seen	NULL
.	NULL
``	NULL

''	NULL
Specific	NULL
nuclear	NULL
staining	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
in	NULL
most	NULL
of	NULL
the	NULL
cells	NULL
within	NULL
these	NULL
structures	NULL
(	NULL
Fig	NULL
4A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

anti-rbox	NULL
+	NULL
GST/runt	NULL
Fig	NULL
2	NULL
.	NULL

-	NULL
Immunofluorescent	NULL
labeling	NULL
of	NULL
adult	NULL
bone	NULL
marrow	NULL
cells	NULL
with	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
Purified	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
(	NULL
anti-rbox	NULL
)	NULL
stains	NULL
the	NULL
nuclei	NULL
of	NULL
bone	NULL
marrow	NULL
cells	NULL
with	NULL
variable	NULL
intensity	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Occasional	NULL
cells	NULL
show	NULL
weak	NULL
cytoplasmic	NULL
staining	NULL
{	NULL
arrow	NULL
)	NULL
,	NULL
but	NULL
this	NULL
is	NULL
also	NULL
visible	NULL
with	NULL
the	NULL
preimmune	NULL
serum	NULL
(	NULL
pre	NULL
)	NULL
(	NULL
B	NULL
,	NULL
arrow	NULL
)	NULL
.	NULL

(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
Staining	NULL
with	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
preincubated	NULL
with	NULL
a	NULL
bacterial	NULL
extract	NULL
containing	NULL
either	NULL
GST	NULL
(	NULL
anti-rbox	NULL
+	NULL
GST	NULL
;	NULL
C	NULL
)	NULL
or	NULL
GST/runt	NULL
(	NULL
anti-rbox	NULL
+	NULL
GST/runt	NULL
;	NULL
D	NULL
)	NULL
.	NULL

The	NULL
staining	NULL
is	NULL
abolished	NULL
only	NULL
in	NULL
the	NULL
latter	NULL
sample	NULL
.	NULL

At	NULL
11.5	NULL
dpc	NULL
,	NULL
the	NULL
yolk	NULL
sac	NULL
is	NULL
near	NULL
the	NULL
end	NULL
of	NULL
its	NULL
erythropoi-etic	NULL
function	NULL
,	NULL
although	NULL
it	NULL
is	NULL
still	NULL
the	NULL
source	NULL
of	NULL
all	NULL
circulating	NULL
erythrocytes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
liver	NULL
is	NULL
the	NULL
expanding	NULL
hematopoietic	NULL
organ	NULL
and	NULL
is	NULL
constituted	NULL
by	NULL
immature	NULL
,	NULL
fast	NULL
growing	NULL
cells	NULL
.	NULL

These	NULL
cells	NULL
are	NULL
almost	NULL
exclusively	NULL
erythroid	NULL
,	NULL
``	NULL
although	NULL
for	NULL
the	NULL
most	NULL
part	NULL
lacking	NULL
the	NULL
erythroid-specific	NULL
marker	NULL
TER-119	NULL
,	NULL
whereas	NULL
they	NULL
are	NULL
strongly	NULL
positive	NULL
for	NULL
c-kit	NULL
.	NULL
``	NULL

''	NULL
On	NULL
wax	NULL
sections	NULL
,	NULL
the	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
stained	NULL
about	NULL
half	NULL
of	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
4C	NULL
and	NULL
D	NULL
)	NULL
with	NULL
variable	NULL
intensity	NULL
.	NULL

Cytospin	NULL
preparations	NULL
were	NULL
also	NULL
made	NULL
from	NULL
the	NULL
liver	NULL
of	NULL
12.5-dpc	NULL
mice	NULL
to	NULL
study	NULL
in	NULL
greater	NULL
detail	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
positive	NULL
cells	NULL
and	NULL
the	NULL
localization	NULL
of	NULL
the	NULL
runt	NULL
box	NULL
polypeptides	NULL
.	NULL

Both	NULL
early	NULL
erythroblasts	NULL
and	NULL
nucleated	NULL
primitive	NULL
erythrocytes	NULL
could	NULL
be	NULL
identified	NULL
(	NULL
Fig	NULL
5A	NULL
through	NULL
D	NULL
)	NULL
.	NULL

The	NULL
former	NULL
,	NULL
which	NULL
are	NULL
easily	NULL
recognizable	NULL
by	NULL
their	NULL
nuclear	NULL
shape	NULL
and	NULL
high	NULL
nucleus/cytoplasmic	NULL
ratio	NULL
,	NULL
showed	NULL
a	NULL
diffuse	NULL
nuclear	NULL
staining	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
latter	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
characterized	NULL
by	NULL
their	NULL
round	NULL
nuclei	NULL
and	NULL
lower	NULL
nucleus/cytoplasmic	NULL
ratio	NULL
,	NULL
staining	NULL
was	NULL
visible	NULL
only	NULL
at	NULL
the	NULL
nucleus/cytoplasmic	NULL
border	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
arrow-heads	NULL
)	NULL
.	NULL

An	NULL
identical	NULL
staining	NULL
pattern	NULL
can	NULL
be	NULL
observed	NULL
in	NULL
the	NULL
nucleated	NULL
primitive	NULL
erythrocytes	NULL
that	NULL
make	NULL
up	NULL
the	NULL
majority	NULL
of	NULL
circulating	NULL
blood	NULL
cells	NULL
at	NULL
this	NULL
stage	NULL
(	NULL
Fig	NULL
5E	NULL
)	NULL
.	NULL

It	NULL
is	NULL
unlikely	NULL
that	NULL
this	NULL
pattern	NULL
is	NULL
due	NULL
to	NULL
a	NULL
fixation	NULL
or	NULL
staining	NULL
artefact	NULL
,	NULL
because	NULL
it	NULL
was	NULL
apparent	NULL
even	NULL
with	NULL
a	NULL
different	NULL
fixative	NULL
(	NULL
ie	NULL
,	NULL
cold	NULL
acetone	NULL
for	NULL
10	NULL
minutes	NULL
)	NULL
and	NULL
with	NULL
a	NULL
peroxidase-conjugated	NULL
anti-rabbit	NULL
reagent	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

At	NULL
16.5	NULL
days	NULL
,	NULL
the	NULL
liver	NULL
contains	NULL
erythroid	NULL
cells	NULL
of	NULL
all	NULL
differentiation	NULL
stages	NULL
,	NULL
displaying	NULL
almost	NULL
all	NULL
the	NULL
characteristics	NULL
of	NULL
the	NULL
adult	NULL
bone	NULL
marrow	NULL
erythroid	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
populations	NULL
differentiating	NULL
toward	NULL
the	NULL
other	NULL
lineages	NULL
can	NULL
be	NULL
shown	NULL
by	NULL
both	NULL
morphologic	NULL
analysis	NULL
and	NULL
staining	NULL
with	NULL
lineage-specific	NULL
antibodies	NULL
.	NULL

Overall	NULL
,	NULL
more	NULL
than	NULL
one	NULL
third	NULL
of	NULL
the	NULL
cells	NULL
express	NULL
nuclear	NULL
runt	NULL
box	NULL
polypeptides	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

The	NULL
perinuclear	NULL
lo	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RUNT	NULL
BOX	NULL
POLYPEPTIDES	NULL
IN	NULL
HEMATOPOIESIS	NULL
anti-rbox	NULL
+	NULL
GST	NULL
nti-r	NULL
x+	NULL
T/run	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
Immunofluorescent	NULL
labeling	NULL
of	NULL
adult	NULL
mouse	NULL
bone	NULL
marrow	NULL
cytospin	NULL
preparations	NULL
with	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
in	NULL
combination	NULL
with	NULL
MoAbs	NULL
specific	NULL
for	NULL
granulocytes	NULL
(	NULL
anti-Gr-1	NULL
;	NULL
A	NULL
and	NULL
B	NULL
)	NULL
and	NULL
erythroid	NULL
cells	NULL
(	NULL
TER-119	NULL
;	NULL
C	NULL
and	NULL
D	NULL
)	NULL
or	NULL
with	NULL
an	NULL
antiserum	NULL
against	NULL
B	NULL
lymphocytes	NULL
(	NULL
anti-mouse	NULL
Ig	NULL
;	NULL
E	NULL
and	NULL
F	NULL
)	NULL
.	NULL

The	NULL
anti-runt	NULL
box	NULL
reactivity	NULL
appears	NULL
as	NULL
red-orange	NULL
(	NULL
R-phycoerythrin	NULL
}	NULL
;	NULL
reactivity	NULL
with	NULL
lineage-specific	NULL
antibodies	NULL
appears	NULL
in	NULL
green	NULL
(	NULL
FITC	NULL
)	NULL
.	NULL

The	NULL
anti-runt	NULL
box	NULL
was	NULL
competed	NULL
with	NULL
GST	NULL
(	NULL
anti-rbox	NULL
+	NULL
GST	NULL
;	NULL
A	NULL
,	NULL
C	NULL
,	NULL
and	NULL
E	NULL
)	NULL
or	NULL
with	NULL
GST/runt	NULL
{	NULL
anti-rbox	NULL
+	NULL
GST/runt	NULL
;	NULL
B	NULL
,	NULL
D	NULL
,	NULL
and	NULL
F	NULL
)	NULL
.	NULL

Double-positive	NULL
cells	NULL
in	NULL
(	NULL
A	NULL
)	NULL
,	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
(	NULL
E	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

bi	NULL
bi	NULL
en	NULL
w	NULL
*	NULL
en	NULL
2363	NULL
anti-rbox	NULL
as	NULL
``	NULL
“	NULL
I	NULL
‘	NULL
”	NULL
b	NULL
ag	NULL
anti-rbox	NULL
+	NULL
GST	NULL
anti-rbox	NULL
+	NULL
GST/runt	NULL
Fig	NULL
6	NULL
.	NULL

-	NULL
Immunofluorescent	NULL
labeling	NULL
of	NULL
16.5-dpc	NULL
fetal	NULL
liver	NULL
cells	NULL
with	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
either	NULL
alone	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
MoAbs	NULL
specific	NULL
for	NULL
granulocytes	NULL
(	NULL
anti-Gr-1	NULL
;	NULL
C	NULL
and	NULL
D	NULL
)	NULL
or	NULL
erythroid	NULL
cells	NULL
{	NULL
TER-119	NULL
;	NULL
E	NULL
and	NULL
F	NULL
)	NULL
.	NULL

The	NULL
anti-runt	NULL
box	NULL
reactivity	NULL
appears	NULL
as	NULL
red-orange	NULL
stain	NULL
(	NULL
R-phycoerythrin	NULL
}	NULL
;	NULL
reactivity	NULL
with	NULL
lineage-specific	NULL
antibodies	NULL
appears	NULL
in	NULL
green	NULL
(	NULL
FITC	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Anti-runt	NULL
box	NULL
staining	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Preimmune	NULL
rabbit	NULL
serum	NULL
control	NULL
.	NULL

Competitions	NULL
with	NULL
GST	NULL
or	NULL
GST	NULL
/runt	NULL
(	NULL
C	NULL
through	NULL
F	NULL
)	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
2	NULL
.	NULL

In	NULL
(	NULL
C	NULL
)	NULL
,	NULL
the	NULL
arrow	NULL
indicates	NULL
a	NULL
large	NULL
blast	NULL
of	NULL
granulocytic	NULL
lineage	NULL
(	NULL
green	NULL
staining	NULL
)	NULL
that	NULL
was	NULL
strongly	NULL
labeled	NULL
by	NULL
the	NULL
anti-runt	NULL
box	NULL
(	NULL
red-orange	NULL
)	NULL
;	NULL
this	NULL
last	NULL
staining	NULL
is	NULL
prevented	NULL
by	NULL
preincubation	NULL
with	NULL
GST/runt	NULL
.	NULL

In	NULL
(	NULL
E	NULL
)	NULL
,	NULL
the	NULL
double-labeled	NULL
cells	NULL
(	NULL
arrowhead	NULL
)	NULL
show	NULL
expression	NULL
of	NULL
runt-box	NULL
polypeptides	NULL
in	NULL
the	NULL
erythroid	NULL
lineage	NULL
,	NULL
albeit	NULL
at	NULL
much	NULL
lower	NULL
levels	NULL
than	NULL
in	NULL
myeloid	NULL
blasts	NULL
(	NULL
long	NULL
arrow	NULL
)	NULL
.	NULL

Even	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
specificity	NULL
of	NULL
the	NULL
anti-runt	NULL
box	NULL
stain	NULL
is	NULL
shown	NULL
by	NULL
competition	NULL
with	NULL
GST/runt	NULL
(	NULL
F	NULL
)	NULL
.	NULL

calization	NULL
observed	NULL
in	NULL
primitive	NULL
erythrocytes	NULL
at	NULL
the	NULL
earlier	NULL
time	NULL
point	NULL
is	NULL
no	NULL
longer	NULL
visible	NULL
.	NULL

Double	NULL
staining	NULL
analyses	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
6C	NULL
through	NULL
F.	NULL
All	NULL
the	NULL
maturing	NULL
(	NULL
Gr-1*	NULL
)	NULL
granulocytic	NULL
elements	NULL
(	NULL
about	NULL
5	NULL
%	NULL
in	NULL
our	NULL
samples	NULL
)	NULL
were	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
Immunohistochemical	NULL
labeling	NULL
of	NULL
early	NULL
erythroid	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Section	NULL
through	NULL
the	NULL
7.5-dpc	NULL
yolk	NULL
sac	NULL
showing	NULL
staining	NULL
for	NULL
runt	NULL
box	NULL
polypeptides	NULL
in	NULL
the	NULL
developing	NULL
blood	NULL
islands	NULL
(	NULL
original	NULL
magnification	NULL
x	NULL
20	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Negative	NULL
control	NULL
for	NULL
(	NULL
A	NULL
)	NULL
,	NULL
ie	NULL
,	NULL
an	NULL
adjacent	NULL
section	NULL
stained	NULL
with	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
after	NULL
preincubation	NULL
with	NULL
GST	NULL
/runt	NULL
polypeptide	NULL
.	NULL

Given	NULL
the	NULL
lack	NULL
of	NULL
stain	NULL
,	NULL
a	NULL
phase	NULL
contrast	NULL
image	NULL
is	NULL
shown	NULL
for	NULL
better	NULL
definition	NULL
(	NULL
original	NULL
magnification	NULL
x	NULL
20	NULL
)	NULL
.	NULL

bi	NULL
,	NULL
blood	NULL
island	NULL
;	NULL
en	NULL
,	NULL
extraembryonic	NULL
endoderm	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Section	NULL
through	NULL
a	NULL
11.5-dpc	NULL
mouse	NULL
embryo	NULL
,	NULL
showing	NULL
staining	NULL
for	NULL
runt	NULL
box	NULL
polypeptides	NULL
in	NULL
the	NULL
fetal	NULL
liver	NULL
{	NULL
Iv	NULL
)	NULL
and	NULL
in	NULL
the	NULL
urogenital	NULL
ridge	NULL
(	NULL
g	NULL
)	NULL
.	NULL

The	NULL
neighboring	NULL
tissues	NULL
are	NULL
negative	NULL
(	NULL
original	NULL
magnification	NULL
x	NULL
20	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Same	NULL
as	NULL
(	NULL
C	NULL
)	NULL
,	NULL
but	NULL
preimmune	NULL
control	NULL
(	NULL
original	NULL
magnification	NULL
x	NULL
20	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2364	NULL
CORSETT	NULL
!	NULL

AND	NULL
CALABI	NULL
anti-rbox	NULL
+	NULL
GST	NULL
12.5	NULL
BLOOD	NULL
anti-rbox	NULL
+	NULL
GST/runt	NULL
anti-rbox	NULL
+	NULL
GST	NULL
strongly	NULL
stained	NULL
for	NULL
runt	NULL
.	NULL

About	NULL
30	NULL
%	NULL
of	NULL
the	NULL
TER-119*	NULL
cells	NULL
were	NULL
stained	NULL
by	NULL
the	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
,	NULL
showing	NULL
that	NULL
runt	NULL
expression	NULL
is	NULL
maintained	NULL
in	NULL
some	NULL
erythroid	NULL
cells	NULL
at	NULL
this	NULL
stage	NULL
.	NULL

The	NULL
proportion	NULL
of	NULL
runt-expressing	NULL
cells	NULL
within	NULL
the	NULL
c-kit*	NULL
population	NULL
was	NULL
lower	NULL
in	NULL
16.5-dpc	NULL
fetal	NULL
liver	NULL
(	NULL
40	NULL
%	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
than	NULL
in	NULL
adult	NULL
bone	NULL
marrow	NULL
(	NULL
70	NULL
%	NULL
;	NULL
see	NULL
above	NULL
)	NULL
.	NULL

This	NULL
correlates	NULL
with	NULL
a	NULL
higher	NULL
proportion	NULL
of	NULL
immature	NULL
precursors	NULL
within	NULL
the	NULL
c-kit	NULL
'	NULL
pool	NULL
of	NULL
the	NULL
former	NULL
tissue	NULL
``	NULL
and	NULL
suggests	NULL
that	NULL
runt	NULL
is	NULL
expressed	NULL
by	NULL
the	NULL
more	NULL
mature	NULL
c-kit*	NULL
cells	NULL
.	NULL

Of	NULL
the	NULL
Mac-1	NULL
*	NULL
cells	NULL
(	NULL
6	NULL
%	NULL
of	NULL
the	NULL
total	NULL
)	NULL
,	NULL
approximately	NULL
60	NULL
%	NULL
expressed	NULL
runt	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
Gr-1*	NULL
granulocytes	NULL
make	NULL
up	NULL
a	NULL
similar	NULL
proportion	NULL
of	NULL
the	NULL
Mac-1*	NULL
population	NULL
and	NULL
they	NULL
are	NULL
all	NULL
runt-positive	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
Mac-1*/	NULL
runt	NULL
cells	NULL
are	NULL
Gr-1~	NULL
,	NULL
ie	NULL
,	NULL
they	NULL
must	NULL
be	NULL
monocytes	NULL
.	NULL

Immunochemical	NULL
analysis	NULL
of	NULL
runt	NULL
box	NULL
polypeptides	NULL
.	NULL

Western	NULL
blotting	NULL
analysis	NULL
on	NULL
adult	NULL
bone	NULL
marrow	NULL
cell	NULL
lysates	NULL
anti-rbox	NULL
+	NULL
GST/runt	NULL
Fig	NULL
5	NULL
.	NULL

Immunofluorescent	NULL
labeling	NULL
of	NULL
cytospin	NULL
preparations	NULL
from	NULL
12.5-dpc	NULL
liver	NULL
and	NULL
blood	NULL
stained	NULL
with	NULL
the	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Anti-runt	NULL
box	NULL
staining	NULL
of	NULL
liver	NULL
cells	NULL
;	NULL
two	NULL
primitive	NULL
erythrocytes	NULL
labeled	NULL
at	NULL
the	NULL
nucleus-cytoplasmic	NULL
border	NULL
are	NULL
indicated	NULL
(	NULL
arrows	NULL
}	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Staining	NULL
with	NULL
preimmune	NULL
serum	NULL
.	NULL

Competition	NULL
experiments	NULL
were	NULL
performed	NULL
on	NULL
12.5-dpc	NULL
liver	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
and	NULL
blood	NULL
(	NULL
E	NULL
and	NULL
F	NULL
)	NULL
as	NULL
for	NULL
bone	NULL
marrow	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

In	NULL
both	NULL
tissues	NULL
,	NULL
the	NULL
staining	NULL
persisted	NULL
after	NULL
preincubation	NULL
with	NULL
GST	NULL
(	NULL
C	NULL
and	NULL
E	NULL
)	NULL
,	NULL
but	NULL
was	NULL
abolished	NULL
after	NULL
preincubation	NULL
with	NULL
GST/runt	NULL
(	NULL
D	NULL
and	NULL
F	NULL
)	NULL
.	NULL

showed	NULL
a	NULL
number	NULL
of	NULL
runt	NULL
box	NULL
polypeptides	NULL
(	NULL
Fig	NULL
7A	NULL
)	NULL
.	NULL

The	NULL
most	NULL
abundant	NULL
component	NULL
migrated	NULL
as	NULL
a	NULL
doublet	NULL
at	NULL
an	NULL
apparent	NULL
molecular	NULL
weight	NULL
of	NULL
53/55	NULL
kD	NULL
,	NULL
and	NULL
minor	NULL
ones	NULL
at	NULL
43/45	NULL
,	NULL
40/41	NULL
,	NULL
and	NULL
34	NULL
kD	NULL
.	NULL

We	NULL
therefore	NULL
designate	NULL
the	NULL
runt	NULL
products	NULL
as	NULL
p53/55-runt	NULL
,	NULL
p43/45-runt	NULL
,	NULL
p40/41-runt	NULL
,	NULL
and	NULL
p34-runt	NULL
.	NULL

Bands	NULL
at	NULL
37	NULL
and	NULL
30	NULL
kD	NULL
were	NULL
recognized	NULL
by	NULL
the	NULL
preimmune	NULL
serum	NULL
(	NULL
Fig	NULL
7A	NULL
,	NULL
asterisks	NULL
)	NULL
and	NULL
were	NULL
not	NULL
competed	NULL
by	NULL
the	NULL
recombinant	NULL
GST/runt	NULL
box	NULL
polypeptide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
they	NULL
must	NULL
be	NULL
regarded	NULL
as	NULL
nonspecific	NULL
.	NULL

In	NULL
some	NULL
,	NULL
but	NULL
not	NULL
all	NULL
experiments	NULL
,	NULL
we	NULL
could	NULL
also	NULL
detect	NULL
an	NULL
additional	NULL
specific	NULL
band	NULL
at	NULL
approximately	NULL
27	NULL
kD	NULL
.	NULL

This	NULL
was	NULL
only	NULL
found	NULL
in	NULL
some	NULL
TO	NULL
mice	NULL
and	NULL
never	NULL
in	NULL
CD1	NULL
,	NULL
and	NULL
may	NULL
suggest	NULL
a	NULL
certain	NULL
variability	NULL
in	NULL
the	NULL
pattern	NULL
of	NULL
runt	NULL
expression	NULL
.	NULL

In	NULL
gen-eral	NULL
,	NULL
the	NULL
relative	NULL
abundance	NULL
of	NULL
the	NULL
various	NULL
species	NULL
appeared	NULL
to	NULL
vary	NULL
to	NULL
a	NULL
certain	NULL
extent	NULL
between	NULL
different	NULL
experiments	NULL
(	NULL
compare	NULL
the	NULL
bone	NULL
marrow	NULL
lanes	NULL
in	NULL
Fig	NULL
7A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

To	NULL
exclude	NULL
that	NULL
the	NULL
apparent	NULL
complexity	NULL
of	NULL
runt	NULL
polypep-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RUNT	NULL
BOX	NULL
POLYPEPTIDES	NULL
IN	NULL
HEMATOPOIESIS	NULL
tides	NULL
shown	NULL
on	NULL
Western	NULL
blotting	NULL
analysis	NULL
was	NULL
due	NULL
to	NULL
partial	NULL
proteolysis	NULL
,	NULL
in	NULL
some	NULL
experiments	NULL
transfected	NULL
COS-7	NULL
cells	NULL
expressing	NULL
the	NULL
AML1a	NULL
polypeptide	NULL
were	NULL
mixed	NULL
with	NULL
bone	NULL
marrow	NULL
cells	NULL
before	NULL
lysis	NULL
and	NULL
electrophoresis	NULL
.	NULL

No	NULL
decrease	NULL
in	NULL
the	NULL
amount	NULL
or	NULL
size	NULL
of	NULL
the	NULL
COS	NULL
cell-derived	NULL
AML1a	NULL
polypeptide	NULL
was	NULL
detected	NULL
in	NULL
comparison	NULL
with	NULL
unmixed	NULL
samples	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
there	NULL
is	NULL
lineage-restricted	NULL
expression	NULL
of	NULL
individual	NULL
runt	NULL
products	NULL
,	NULL
Western	NULL
blotting	NULL
was	NULL
also	NULL
performed	NULL
on	NULL
purified	NULL
bone	NULL
marrow	NULL
subpopulations	NULL
expressing	NULL
CD4SR	NULL
,	NULL
Gr-1	NULL
,	NULL
or	NULL
TER-119	NULL
markers	NULL
.	NULL

B	NULL
lymphocytes	NULL
and	NULL
granulocytes	NULL
account	NULL
for	NULL
most	NULL
,	NULL
if	NULL
not	NULL
all	NULL
,	NULL
of	NULL
the	NULL
runt-box	NULL
polypeptides	NULL
in	NULL
the	NULL
whole	NULL
bone	NULL
marrow	NULL
(	NULL
Fig	NULL
7A	NULL
)	NULL
.	NULL

All	NULL
of	NULL
the	NULL
described	NULL
runt	NULL
products	NULL
appear	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
p34-runt	NULL
,	NULL
which	NULL
is	NULL
significantly	NULL
enriched	NULL
in	NULL
the	NULL
myeloid	NULL
cells	NULL
,	NULL
while	NULL
totally	NULL
absent	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
Gr-1*	NULL
population	NULL
shows	NULL
a	NULL
higher	NULL
average	NULL
content	NULL
of	NULL
p53/55-runt	NULL
than	NULL
do	NULL
total	NULL
marrow	NULL
or	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
only	NULL
the	NULL
smaller	NULL
component	NULL
of	NULL
the	NULL
p40/41-runt	NULL
doublet	NULL
is	NULL
visible	NULL
.	NULL

In	NULL
Fig	NULL
7A	NULL
,	NULL
other	NULL
slower	NULL
migrating	NULL
species	NULL
seem	NULL
also	NULL
to	NULL
be	NULL
enriched	NULL
in	NULL
either	NULL
myeloid	NULL
or	NULL
B	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
these	NULL
results	NULL
were	NULL
not	NULL
reproducible	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
immunohisto-chemistry	NULL
data	NULL
,	NULL
no	NULL
specific	NULL
runt	NULL
signal	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
the	NULL
adult	NULL
TER-119*	NULL
(	NULL
erythroid	NULL
)	NULL
population	NULL
.	NULL

Western	NULL
blotting	NULL
analysis	NULL
was	NULL
also	NULL
performed	NULL
on	NULL
fetal	NULL
liver	NULL
cell	NULL
lysates	NULL
from	NULL
12.5-	NULL
and	NULL
16.5-dpc	NULL
embryos	NULL
(	NULL
Fig	NULL
7B	NULL
)	NULL
.	NULL

The	NULL
pattern	NULL
is	NULL
essentially	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
whole	NULL
adult	NULL
bone	NULL
marrow	NULL
.	NULL

However	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
bands	NULL
decreases	NULL
with	NULL
developmental	NULL
age	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
runt	NULL
box	NULL
polypeptides	NULL
in	NULL
erythroid	NULL
(	NULL
TER-119*	NULL
)	NULL
populations	NULL
from	NULL
16.5	NULL
fetal	NULL
liver	NULL
,	NULL
but	NULL
not	NULL
from	NULL
adult	NULL
bone	NULL
marrow	NULL
,	NULL
is	NULL
unlikely	NULL
to	NULL
be	NULL
due	NULL
solely	NULL
to	NULL
a	NULL
different	NULL
cellular	NULL
complexity	NULL
.	NULL

Morphologic	NULL
analysis	NULL
by	NULL
May-Griinwald-Giemsa	NULL
staining	NULL
showed	NULL
that	NULL
the	NULL
samples	NULL
had	NULL
a	NULL
similar	NULL
composition	NULL
in	NULL
differentiated	NULL
elements	NULL
,	NULL
whereas	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
relative	NULL
content	NULL
of	NULL
nucleated	NULL
cells	NULL
(	NULL
56	NULL
%	NULL
in	NULL
the	NULL
16.5-day	NULL
fetal	NULL
liver	NULL
sample	NULL
against	NULL
22	NULL
%	NULL
in	NULL
the	NULL
adult	NULL
bone	NULL
marrow	NULL
sample	NULL
)	NULL
was	NULL
less	NULL
than	NULL
3	NULL
times	NULL
.	NULL

We	NULL
also	NULL
investigated	NULL
the	NULL
runt	NULL
box	NULL
polypeptides	NULL
expressed	NULL
at	NULL
other	NULL
adult	NULL
hematopoietic	NULL
sites	NULL
,	NULL
ie	NULL
,	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
peritoneal	NULL
macrophages	NULL
(	NULL
Fig	NULL
7C	NULL
)	NULL
.	NULL

All	NULL
of	NULL
the	NULL
examined	NULL
samples	NULL
express	NULL
p53/55-runt	NULL
,	NULL
p43/45-runt	NULL
,	NULL
and	NULL
p40/41-runt	NULL
,	NULL
although	NULL
their	NULL
relative	NULL
abundance	NULL
varies	NULL
.	NULL

For	NULL
example	NULL
,	NULL
p40/41-runt	NULL
is	NULL
the	NULL
prevalent	NULL
species	NULL
in	NULL
peritoneal	NULL
macro-phages	NULL
,	NULL
although	NULL
it	NULL
could	NULL
not	NULL
be	NULL
clearly	NULL
detected	NULL
in	NULL
the	NULL
thy-mus	NULL
.	NULL

p34-runt	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
any	NULL
of	NULL
these	NULL
tissues	NULL
.	NULL

DISCUSSION	NULL
The	NULL
involvement	NULL
of	NULL
a	NULL
human	NULL
runt	NULL
homologue	NULL
(	NULL
CBFAZ	NULL
,	NULL
at	NULL
21q22	NULL
)	NULL
in	NULL
a	NULL
number	NULL
of	NULL
leukemia-associated	NULL
chromosome	NULL
translocations	NULL
``	NULL
suggests	NULL
that	NULL
it	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
hematopoiesis	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
finding	NULL
,	NULL
runt	NULL
products	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
able	NULL
to	NULL
regulate	NULL
genes	NULL
whose	NULL
expression	NULL
is	NULL
characteristic	NULL
of	NULL
differentiated	NULL
blood	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
to	NULL
modulate	NULL
the	NULL
ability	NULL
of	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
to	NULL
differentiate	NULL
in	NULL
vitro	NULL
,	NULL
``	NULL
``	NULL
and	NULL
to	NULL
be	NULL
required	NULL
for	NULL
normal	NULL
fetal	NULL
liver	NULL
hematopoie-sis	NULL
.	NULL
``	NULL

However	NULL
,	NULL
a	NULL
satisfactory	NULL
definition	NULL
of	NULL
the	NULL
role	NULL
of	NULL
mammalian	NULL
runt	NULL
genes	NULL
in	NULL
hematopoiesis	NULL
requires	NULL
a	NULL
detailed	NULL
analy-	NULL
2365	NULL
sis	NULL
of	NULL
their	NULL
pattern	NULL
of	NULL
expression	NULL
within	NULL
the	NULL
different	NULL
lineages	NULL
and	NULL
at	NULL
different	NULL
stages	NULL
.	NULL

This	NULL
is	NULL
of	NULL
particular	NULL
interest	NULL
in	NULL
view	NULL
of	NULL
the	NULL
distinctive	NULL
leukemic	NULL
phenotypes	NULL
associated	NULL
with	NULL
different	NULL
CBFA2	NULL
rearrangements	NULL
.	NULL

Furthermore	NULL
,	NULL
although	NULL
a	NULL
number	NULL
of	NULL
runt	NULL
isoforms	NULL
have	NULL
been	NULL
predicted	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
cDNA	NULL
cloning	NULL
,	NULL
their	NULL
direct	NULL
biochemical	NULL
analysis	NULL
has	NULL
so	NULL
far	NULL
lagged	NULL
behind	NULL
.	NULL

We	NULL
have	NULL
approached	NULL
these	NULL
issues	NULL
by	NULL
developing	NULL
an	NULL
antiserum	NULL
specific	NULL
for	NULL
runt	NULL
polypeptides	NULL
.	NULL

This	NULL
antiserum	NULL
was	NULL
raised	NULL
against	NULL
the	NULL
NH	NULL
,	NULL
-terminal	NULL
half	NULL
of	NULL
the	NULL
human	NULL
runt	NULL
box	NULL
encoded	NULL
by	NULL
the	NULL
CBFAZ	NULL
locus	NULL
.	NULL

However	NULL
,	NULL
given	NULL
the	NULL
degree	NULL
of	NULL
both	NULL
inter-species	NULL
and	NULL
inter-isotype	NULL
sequence	NULL
conservation	NULL
,	NULL
it	NULL
must	NULL
be	NULL
expected	NULL
to	NULL
recognize	NULL
all	NULL
the	NULL
known	NULL
runt	NULL
box-containing	NULL
polypeptides	NULL
.	NULL

The	NULL
antiserum	NULL
has	NULL
been	NULL
used	NULL
first	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
hematopoietic	NULL
lineage/stage	NULL
markers	NULL
,	NULL
for	NULL
an	NULL
analysis	NULL
of	NULL
expression	NULL
at	NULL
the	NULL
single-cell	NULL
level	NULL
and	NULL
,	NULL
second	NULL
,	NULL
for	NULL
biochemical	NULL
characterization	NULL
.	NULL

At	NULL
the	NULL
cellular	NULL
level	NULL
in	NULL
adult	NULL
mouse	NULL
bone	NULL
marrow	NULL
,	NULL
runt	NULL
polypeptides	NULL
are	NULL
found	NULL
in	NULL
differentiating	NULL
granulocytic	NULL
and	NULL
B-lymphoid	NULL
cells	NULL
.	NULL

They	NULL
are	NULL
also	NULL
found	NULL
in	NULL
other	NULL
hematopoietic	NULL
lineages	NULL
outside	NULL
the	NULL
bone	NULL
marrow	NULL
(	NULL
ie	NULL
,	NULL
thymocytes	NULL
and	NULL
peritoneal	NULL
macrophages	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
even	NULL
within	NULL
the	NULL
hematopoietic	NULL
system	NULL
,	NULL
runt	NULL
expression	NULL
does	NULL
not	NULL
coincide	NULL
with	NULL
commitment	NULL
to	NULL
a	NULL
single	NULL
lineage	NULL
.	NULL

Typical	NULL
,	NULL
mature	NULL
granulocytes	NULL
in	NULL
mouse	NULL
bone	NULL
marrow	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
negative	NULL
for	NULL
chfa2	NULL
mRNA	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL
``	NULL

The	NULL
discrepancy	NULL
with	NULL
our	NULL
results	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
different	NULL
sensitivity	NULL
of	NULL
the	NULL
techniques	NULL
used	NULL
.	NULL

We	NULL
have	NULL
found	NULL
the	NULL
smaller	NULL
,	NULL
doughnut-shaped	NULL
cells	NULL
to	NULL
give	NULL
the	NULL
weakest	NULL
runt	NULL
signals	NULL
.	NULL

Alternatively	NULL
,	NULL
runt	NULL
polypeptides	NULL
may	NULL
persist	NULL
in	NULL
late	NULL
myelocytes	NULL
well	NULL
after	NULL
their	NULL
synthesis	NULL
has	NULL
ceased	NULL
,	NULL
reflecting	NULL
a	NULL
slow	NULL
turnover	NULL
,	NULL
as	NULL
reported	NULL
for	NULL
other	NULL
myeloid	NULL
pro-teins	NULL
.	NULL
``	NULL

Within	NULL
the	NULL
erythroid	NULL
lineage	NULL
,	NULL
runt	NULL
expression	NULL
undergoes	NULL
two	NULL
phases	NULL
during	NULL
ontogenesis	NULL
.	NULL

Whereas	NULL
runt	NULL
products	NULL
are	NULL
essentially	NULL
undetectable	NULL
in	NULL
the	NULL
adult	NULL
,	NULL
they	NULL
are	NULL
clearly	NULL
expressed	NULL
in	NULL
the	NULL
embryo	NULL
.	NULL

This	NULL
is	NULL
true	NULL
not	NULL
only	NULL
of	NULL
the	NULL
yolk	NULL
sac	NULL
stage	NULL
,	NULL
but	NULL
also	NULL
at	NULL
least	NULL
of	NULL
the	NULL
beginning	NULL
of	NULL
the	NULL
liver	NULL
phase	NULL
(	NULL
11.5	NULL
dpc	NULL
)	NULL
.	NULL

However	NULL
,	NULL
by	NULL
late	NULL
fetal	NULL
life	NULL
(	NULL
16.5	NULL
dpc	NULL
)	NULL
the	NULL
frequency	NULL
of	NULL
runt-positive	NULL
erythroid	NULL
precursors	NULL
in	NULL
the	NULL
liver	NULL
de-creases	NULL
.	NULL

This	NULL
decrease	NULL
may	NULL
correlate	NULL
with	NULL
the	NULL
different	NULL
ori-gin	NULL
,	NULL
during	NULL
ontogenesis	NULL
,	NULL
of	NULL
fetal	NULL
liver	NULL
erythroid	NULL
precursors	NULL
.	NULL

It	NULL
is	NULL
currently	NULL
generally	NULL
accepted	NULL
that	NULL
sequential	NULL
waves	NULL
of	NULL
hematopoietic	NULL
activity	NULL
are	NULL
contributed	NULL
to	NULL
the	NULL
fetal	NULL
liver	NULL
by	NULL
extra-embryonic	NULL
(	NULL
ie	NULL
,	NULL
the	NULL
yolk	NULL
sac	NULL
)	NULL
and	NULL
intra-embryonic	NULL
(	NULL
the	NULL
AGM	NULL
region	NULL
)	NULL
sources	NULL
.	NULL
``	NULL

''	NULL
The	NULL
decrease	NULL
in	NULL
runt	NULL
expression	NULL
may	NULL
parallel	NULL
the	NULL
decline	NULL
in	NULL
erythropoieitic	NULL
activity	NULL
of	NULL
yolk	NULL
sac	NULL
progenitors	NULL
,	NULL
which	NULL
are	NULL
replaced	NULL
by	NULL
intra-embryonic	NULL
progeni-tors	NULL
.	NULL

Recent	NULL
experiments	NULL
have	NULL
shown	NULL
that	NULL
,	NULL
whereas	NULL
liver	NULL
hematopoiesis	NULL
appears	NULL
to	NULL
require	NULL
a	NULL
functional	NULL
CBFAZ	NULL
locus	NULL
,	NULL
yolk	NULL
sac	NULL
erythropoiesis	NULL
would	NULL
not	NULL
.	NULL
``	NULL

''	NULL
In	NULL
the	NULL
light	NULL
of	NULL
our	NULL
experimental	NULL
evidence	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
runt	NULL
polypeptides	NULL
in	NULL
the	NULL
yolk	NULL
sac	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
two	NULL
hypotheses	NULL
.	NULL

First	NULL
,	NULL
because	NULL
our	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
would	NULL
cross-react	NULL
with	NULL
CBFAl	NULL
and	NULL
CBFA3	NULL
products	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
either	NULL
or	NULL
both	NULL
latter	NULL
loci	NULL
,	NULL
rather	NULL
than	NULL
CBFA2	NULL
,	NULL
are	NULL
expressed	NULL
in	NULL
the	NULL
yolk	NULL
sac	NULL
.	NULL

Second	NULL
,	NULL
although	NULL
normally	NULL
expressed	NULL
and	NULL
presumably	NULL
required	NULL
in	NULL
yolk	NULL
sac	NULL
hematopoiesis	NULL
,	NULL
CBFAZ	NULL
products	NULL
may	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2366	NULL
A	NULL
B	NULL
md	NULL
A	NULL
r	NULL
ts	NULL
A	NULL
nd	NULL
2	NULL
O	NULL
0	NULL
2	NULL
[	NULL
O	NULL
--	NULL
-	NULL
{	NULL
1	NULL
-at	NULL
94	NULL
amma	NULL
-	NULL
<	NULL
67	NULL
p53/55	NULL
[	NULL
>	NULL
»	NULL
q	NULL
p43/45	NULL
[	NULL
>	NULL
fees	NULL
call	NULL
43	NULL
p40/41	NULL
[	NULL
>	NULL
*	NULL
A	NULL
y	NULL
p34	NULL
p	NULL
>	NULL
$	NULL
«	NULL
cpmmame	NULL
*	NULL
<	NULL
<	NULL
30	NULL
<	NULL
=	NULL
20	NULL
L_	NULL
222222	NULL
pre	NULL
anti-rbox	NULL
CORSETT	NULL
!	NULL

AND	NULL
CALABI	NULL
£0	NULL
g	NULL
3	NULL
<	NULL
0	NULL
9s	NULL
a	NULL
5	NULL
ie	NULL
30	NULL
3	NULL
2	NULL
2	NULL
-	NULL
-	NULL
mq	NULL
p3	NULL
E-	NULL
u	NULL
-	NULL
<	NULL
94	NULL
waa	NULL
94	NULL
-	NULL
<	NULL
67	NULL
.	NULL

e	NULL
f	NULL
<	NULL
=	NULL
67	NULL
t	NULL
aa	NULL
E	NULL
.	NULL

#	NULL
s	NULL
<	NULL
43	NULL
|	NULL
cht	NULL
-	NULL
<	NULL
43	NULL
%	NULL
me	NULL
E	NULL
>	NULL
-	NULL
<	NULL
30	NULL
~	NULL
30	NULL
<	NULL
20	NULL
-as	NULL
20	NULL
Fig	NULL
7	NULL
.	NULL

Western	NULL
blotting	NULL
analysis	NULL
of	NULL
hematopoietic	NULL
cell	NULL
populations	NULL
with	NULL
the	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Lysates	NULL
from	NULL
total	NULL
bone	NULL
marrow	NULL
cells	NULL
(	NULL
Tot	NULL
)	NULL
or	NULL
from	NULL
bone	NULL
marrow	NULL
subpopulations	NULL
enriched	NULL
for	NULL
expression	NULL
of	NULL
CD45R	NULL
,	NULL
Gr-1	NULL
(	NULL
GR	NULL
)	NULL
,	NULL
and	NULL
TER-119	NULL
(	NULL
TER	NULL
)	NULL
.	NULL

pre	NULL
,	NULL
preimmune	NULL
serum	NULL
;	NULL
anti-rbox	NULL
,	NULL
anti-runt	NULL
box	NULL
antiserum	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Lysates	NULL
from	NULL
12.5-	NULL
and	NULL
16.5-dpc	NULL
liver	NULL
cells	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Lysates	NULL
from	NULL
peritoneal	NULL
macrophages	NULL
(	NULL
Mq	NULL
)	NULL
,	NULL
thymus	NULL
,	NULL
and	NULL
spleen	NULL
cells	NULL
.	NULL

The	NULL
total	NULL
bone	NULL
marrow	NULL
lysate	NULL
(	NULL
BM	NULL
)	NULL
is	NULL
shown	NULL
for	NULL
reference	NULL
.	NULL

In	NULL
all	NULL
panels	NULL
,	NULL
each	NULL
lane	NULL
corresponds	NULL
to	NULL
10	NULL
``	NULL
cells	NULL
.	NULL

Specifically	NULL
detected	NULL
polypeptides	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
open	NULL
arrowheads	NULL
on	NULL
the	NULL
left	NULL
,	NULL
with	NULL
the	NULL
estimated	NULL
molecular	NULL
weight	NULL
given	NULL
.	NULL

Asterisks	NULL
mark	NULL
nonspecific	NULL
bands	NULL
{	NULL
see	NULL
text	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
(	NULL
solid	NULL
arrows	NULL
)	NULL
.	NULL

be	NULL
functionally	NULL
replaced	NULL
,	NULL
within	NULL
this	NULL
system	NULL
,	NULL
by	NULL
other	NULL
gene	NULL
products	NULL
.	NULL

Analogous	NULL
examples	NULL
of	NULL
plasticity	NULL
and	NULL
functional	NULL
redundancy	NULL
have	NULL
been	NULL
described	NULL
in	NULL
several	NULL
other	NULL
developmental	NULL
pathways	NULL
.	NULL

A	NULL
number	NULL
of	NULL
genes	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
yolk	NULL
sac	NULL
hematopoiesis	NULL
,	NULL
eg	NULL
,	NULL
GATA-I	NULL
,	NULL
tall	NULL
,	NULL
rbtn2	NULL
,	NULL
and	NULL
GATA-2	NULL
.	NULL

``	NULL
*	NULL
It	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
investigate	NULL
the	NULL
relationships	NULL
,	NULL
if	NULL
any	NULL
,	NULL
between	NULL
these	NULL
genes	NULL
and	NULL
runt	NULL
.	NULL

Although	NULL
runt	NULL
polypeptides	NULL
are	NULL
clearly	NULL
expressed	NULL
in	NULL
maturing	NULL
granulocytes	NULL
,	NULL
B	NULL
lymphocytes	NULL
,	NULL
and	NULL
monocytes	NULL
,	NULL
their	NULL
presence	NULL
at	NULL
earlier	NULL
differentiation	NULL
stages	NULL
remains	NULL
to	NULL
be	NULL
investi-gated	NULL
.	NULL

Our	NULL
data	NULL
on	NULL
c-kit	NULL
``	NULL
cells	NULL
suggest	NULL
that	NULL
they	NULL
are	NULL
expressed	NULL
before	NULL
overt	NULL
lineage	NULL
differentiation	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
have	NULL
preliminary	NULL
evidence	NULL
that	NULL
human	NULL
CD34*	NULL
cells	NULL
are	NULL
runt-positive	NULL
(	NULL
M.T.C	NULL
.	NULL

,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

At	NULL
the	NULL
biochemical	NULL
level	NULL
,	NULL
our	NULL
analysis	NULL
shows	NULL
that	NULL
a	NULL
number	NULL
of	NULL
runt	NULL
box	NULL
polypeptides	NULL
are	NULL
present	NULL
in	NULL
both	NULL
primitive	NULL
and	NULL
definitive	NULL
hematopoietic	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
not	NULL
established	NULL
the	NULL
precise	NULL
identity	NULL
of	NULL
the	NULL
various	NULL
species	NULL
observed	NULL
.	NULL

However	NULL
,	NULL
they	NULL
can	NULL
be	NULL
correlated	NULL
with	NULL
the	NULL
isoforms	NULL
predicted	NULL
from	NULL
cDNA	NULL
sequences	NULL
by	NULL
comparison	NULL
of	NULL
the	NULL
observed	NULL
with	NULL
the	NULL
expected	NULL
molecular	NULL
weights	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
p53/55-runt	NULL
that	NULL
is	NULL
the	NULL
major	NULL
component	NULL
in	NULL
both	NULL
total	NULL
bone	NULL
marrow	NULL
and	NULL
purified	NULL
granulocytic	NULL
and	NULL
lymphoid	NULL
subpopulations	NULL
may	NULL
correspond	NULL
to	NULL
a	NULL
CBFA1l	NULL
and/or	NULL
to	NULL
a	NULL
CBFAZ	NULL
isoform	NULL
(	NULL
ie	NULL
,	NULL
the	NULL
A1	NULL
``	NULL
or	NULL
the	NULL
B1°	NULL
isoform	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

A	NULL
slightly	NULL
higher	NULL
molecular	NULL
weight	NULL
has	NULL
been	NULL
reported	NULL
for	NULL
the	NULL
former	NULL
expressed	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL
``	NULL

p40/41	NULL
runt	NULL
may	NULL
correspond	NULL
to	NULL
the	NULL
CBFAZ	NULL
B2	NULL
iso-form©	NULL
and	NULL
p34	NULL
runt	NULL
may	NULL
correspond	NULL
to	NULL
the	NULL
CBFA1	NULL
AZ	NULL
iso-form	NULL
.	NULL
``	NULL

As	NULL
for	NULL
the	NULL
p43/45	NULL
runt	NULL
,	NULL
it	NULL
may	NULL
correspond	NULL
to	NULL
the	NULL
product	NULL
of	NULL
the	NULL
CBFA3	NULL
locus	NULL
,	NULL
based	NULL
on	NULL
the	NULL
sequence	NULL
of	NULL
a	NULL
human	NULL
cDNA	NULL
.	NULL
``	NULL

The	NULL
three	NULL
largest	NULL
species	NULL
appear	NULL
as	NULL
doublets	NULL
,	NULL
ie	NULL
,	NULL
two	NULL
closely	NULL
spaced	NULL
bands	NULL
of	NULL
roughly	NULL
similar	NULL
abundance	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
they	NULL
share	NULL
a	NULL
similar	NULL
type	NULL
of	NULL
modification	NULL
(	NULL
eg	NULL
,	NULL
phosphorylation	NULL
)	NULL
.	NULL

The	NULL
variable	NULL
ratio	NULL
between	NULL
individual	NULL
species	NULL
may	NULL
indicate	NULL
that	NULL
their	NULL
relative	NULL
balance	NULL
is	NULL
dynamic	NULL
and	NULL
possibly	NULL
correlated	NULL
with	NULL
different	NULL
functional	NULL
states	NULL
.	NULL

Clearly	NULL
,	NULL
at	NULL
least	NULL
some	NULL
of	NULL
the	NULL
complexity	NULL
of	NULL
runt	NULL
box	NULL
polypeptides	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
may	NULL
be	NULL
due	NULL
to	NULL
cellular	NULL
heteroge-neity	NULL
.	NULL

However	NULL
,	NULL
with	NULL
one	NULL
notable	NULL
exception	NULL
(	NULL
the	NULL
p34	NULL
runt	NULL
,	NULL
which	NULL
is	NULL
specific	NULL
to	NULL
granulocytes	NULL
)	NULL
,	NULL
a	NULL
largely	NULL
similar	NULL
pattern	NULL
was	NULL
observed	NULL
in	NULL
more	NULL
homogenous	NULL
subpopulations	NULL
of	NULL
individual	NULL
lineages	NULL
,	NULL
ie	NULL
,	NULL
relatively	NULL
mature	NULL
granulocytes	NULL
,	NULL
B	NULL
lymphocytes	NULL
,	NULL
thymocytes	NULL
,	NULL
and	NULL
embryonic	NULL
erythroid	NULL
precursors	NULL
.	NULL

It	NULL
can	NULL
be	NULL
concluded	NULL
that	NULL
the	NULL
components	NULL
of	NULL
this	NULL
pattern	NULL
(	NULL
ie	NULL
,	NULL
p53/55	NULL
runt	NULL
,	NULL
p43/45	NULL
runt	NULL
,	NULL
and	NULL
p40/41	NULL
runt	NULL
)	NULL
are	NULL
not	NULL
sufficient	NULL
per	NULL
se	NULL
to	NULL
induce	NULL
lineage	NULL
commitment	NULL
in	NULL
hematopoietic	NULL
precursors	NULL
.	NULL

It	NULL
remains	NULL
possible	NULL
that	NULL
they	NULL
play	NULL
a	NULL
role	NULL
in	NULL
this	NULL
process	NULL
or	NULL
that	NULL
they	NULL
are	NULL
involved	NULL
in	NULL
postcommitment	NULL
events	NULL
shared	NULL
by	NULL
the	NULL
different	NULL
lineages	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
data	NULL
presented	NULL
here	NULL
bear	NULL
on	NULL
the	NULL
relationship	NULL
between	NULL
rearrangements	NULL
at	NULL
the	NULL
human	NULL
CBFAZ	NULL
locus	NULL
and	NULL
leukemia	NULL
.	NULL

Both	NULL
myeloid	NULL
and	NULL
lymphoid	NULL
leukemia	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
translocations	NULL
involving	NULL
this	NULL
locus	NULL
,	NULL
``	NULL
*	NULL
although	NULL
the	NULL
two	NULL
types	NULL
correlate	NULL
with	NULL
different	NULL
breakpoint	NULL
positions	NULL
.	NULL

The	NULL
phenotypes	NULL
of	NULL
the	NULL
leukemic	NULL
populations	NULL
resemble	NULL
either	NULL
of	NULL
the	NULL
main	NULL
cellular	NULL
types	NULL
expressing	NULL
runt	NULL
polypeptides	NULL
in	NULL
normal	NULL
bone	NULL
marrow	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
immunopheno-type	NULL
of	NULL
t	NULL
(	NULL
12	NULL
;	NULL
21	NULL
)	NULL
leukemias	NULL
(	NULL
HLA-DR*	NULL
,	NULL
CD10*	NULL
,	NULL
and	NULL
CD19*	NULL
)	NULL
indicates	NULL
a	NULL
B-cell	NULL
origin	NULL
and	NULL
correlates	NULL
with	NULL
runt	NULL
expression	NULL
in	NULL
normal	NULL
marrow	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
phenotype	NULL
of	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
AML	NULL
,	NULL
which	NULL
is	NULL
characterized	NULL
by	NULL
a	NULL
certain	NULL
degree	NULL
of	NULL
maturation	NULL
within	NULL
the	NULL
leukemic	NULL
clone	NULL
,	NULL
correlates	NULL
with	NULL
CBFA	NULL
expression	NULL
in	NULL
differentiating	NULL
myelocytes	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
leukemic	NULL
transformation	NULL
has	NULL
a	NULL
requirement	NULL
for	NULL
the	NULL
same	NULL
conditions	NULL
that	NULL
allow	NULL
normal	NULL
CBFA	NULL
expression	NULL
or	NULL
action	NULL
,	NULL
rather	NULL
than	NULL
being	NULL
due	NULL
to	NULL
inappropriate	NULL
lineage	NULL
or	NULL
stage	NULL
expression	NULL
.	NULL

It	NULL
may	NULL
be	NULL
expected	NULL
that	NULL
other	NULL
lineages	NULL
expressing	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RUNT	NULL
BOX	NULL
POLYPEPTIDES	NULL
IN	NULL
HEMATOPOIESIS	NULL
runt	NULL
polypeptides	NULL
are	NULL
susceptible	NULL
to	NULL
leukemic	NULL
transformation	NULL
upon	NULL
mutation	NULL
at	NULL
one	NULL
of	NULL
the	NULL
CBFA	NULL
loci	NULL
.	NULL

Alternatively	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
novel	NULL
translocated	NULL
product	NULL
(	NULL
s	NULL
)	NULL
encoded	NULL
by	NULL
a	NULL
rearranged	NULL
CBFA2	NULL
locus	NULL
competes	NULL
or	NULL
synergizes	NULL
selectively	NULL
with	NULL
a	NULL
lineage-	NULL
or	NULL
stage-specific	NULL
runt	NULL
isoform	NULL
.	NULL

A	NULL
prime	NULL
candidate	NULL
in	NULL
the	NULL
myeloid	NULL
lineage	NULL
would	NULL
be	NULL
the	NULL
p34-runt	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
are	NULL
very	NULL
grateful	NULL
to	NULL
Dr	NULL
A.	NULL
Daga	NULL
for	NULL
assembling	NULL
the	NULL
pGEX/	NULL
runt	NULL
box	NULL
construct	NULL
,	NULL
to	NULL
Drs	NULL
A.	NULL
Fleming	NULL
and	NULL
A.	NULL
Copp	NULL
for	NULL
providing	NULL
time-mated	NULL
mice	NULL
,	NULL
to	NULL
Dr	NULL
K.	NULL
Kotowicz	NULL
for	NULL
help	NULL
with	NULL
the	NULL
VarioMACS	NULL
System	NULL
,	NULL
to	NULL
Dr	NULL
H.	NULL
Kempski	NULL
for	NULL
help	NULL
with	NULL
the	NULL
Photometrics	NULL
CCD	NULL
camera	NULL
,	NULL
to	NULL
Prof	NULL
P.	NULL
Thorogood	NULL
for	NULL
encouragement	NULL
,	NULL
and	NULL
to	NULL
Prof	NULL
P.	NULL
Thorogood	NULL
and	NULL
Dr	NULL
I.	NULL
Vielle-Grosjean	NULL
for	NULL
critically	NULL
reading	NULL
the	NULL
manu-script	NULL
.	NULL

We	NULL
thank	NULL
Prof	NULL
J.	NULL
Goldman	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Haematol-ogy	NULL
,	NULL
Royal	NULL
Postgraduate	NULL
Medical	NULL
School	NULL
,	NULL
for	NULL
their	NULL
generous	NULL
hospitality	NULL
during	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
this	NULL
work	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Gergen	NULL
JP	NULL
,	NULL
Wieschaus	NULL
E	NULL
:	NULL
Dosage	NULL
requirements	NULL
for	NULL
runt	NULL
in	NULL
the	NULL
segmentation	NULL
of	NULL
Drosophila	NULL
embryos	NULL
.	NULL

Cell	NULL
45:289	NULL
,	NULL
1986	NULL
2	NULL
.	NULL

Duffy	NULL
JB	NULL
,	NULL
Gergen	NULL
JP	NULL
:	NULL
The	NULL
Drosophila	NULL
segmentation	NULL
gene	NULL
runt	NULL
acts	NULL
as	NULL
a	NULL
position-specific	NULL
numerator	NULL
element	NULL
necessary	NULL
for	NULL
the	NULL
uniform	NULL
expression	NULL
of	NULL
the	NULL
sex-determining	NULL
gene	NULL
Sex-lethal	NULL
.	NULL

Genes	NULL
Dev	NULL
5:2176	NULL
,	NULL
1991	NULL
3	NULL
.	NULL

Duffy	NULL
JB	NULL
,	NULL
Kania	NULL
MA	NULL
,	NULL
Gergen	NULL
JP	NULL
:	NULL
Expression	NULL
and	NULL
function	NULL
of	NULL
the	NULL
Drosophila	NULL
gene	NULL
runt	NULL
in	NULL
early	NULL
stages	NULL
of	NULL
neural	NULL
development	NULL
.	NULL

Development	NULL
113:1223	NULL
,	NULL
1991	NULL
4	NULL
.	NULL

Miyoshi	NULL
H	NULL
,	NULL
Shimizu	NULL
K	NULL
,	NULL
Kozu	NULL
T	NULL
,	NULL
Maseki	NULL
N	NULL
,	NULL
Kaneko	NULL
Y	NULL
,	NULL
Ohki	NULL
M	NULL
:	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
breakpoints	NULL
on	NULL
chromosome	NULL
21	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
are	NULL
clustered	NULL
within	NULL
a	NULL
limited	NULL
region	NULL
of	NULL
a	NULL
single	NULL
gene	NULL
,	NULL
AMLJI	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:10431	NULL
,	NULL
1991	NULL
5	NULL
.	NULL

Daga	NULL
A	NULL
,	NULL
Tighe	NULL
JE	NULL
,	NULL
Calabi	NULL
F	NULL
:	NULL
Leukaemia/Drosophila	NULL
homology	NULL
.	NULL

Nature	NULL
356:484	NULL
,	NULL
1992	NULL
6	NULL
.	NULL

Bae	NULL
S-C	NULL
,	NULL
Ogawa	NULL
E	NULL
,	NULL
Maruyama	NULL
M	NULL
,	NULL
Oka	NULL
H	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Shigesada	NULL
K	NULL
,	NULL
Jenkins	NULL
N	NULL
,	NULL
Gilbert	NULL
D	NULL
,	NULL
Copeland	NULL
N	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
AML1	NULL
consists	NULL
of	NULL
multiple	NULL
isoforms	NULL
that	NULL
possess	NULL
differential	NULL
trans-activation	NULL
potentials	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:3242	NULL
,	NULL
1994	NULL
7	NULL
.	NULL

Levanon	NULL
D	NULL
,	NULL
Negreanu	NULL
V	NULL
,	NULL
Bernstein	NULL
Y	NULL
,	NULL
Bar-Ham	NULL
I	NULL
,	NULL
Avivi	NULL
L	NULL
,	NULL
Groner	NULL
Y	NULL
:	NULL
AML	NULL
1	NULL
,	NULL
AML2	NULL
,	NULL
and	NULL
AML	NULL
3	NULL
,	NULL
the	NULL
human	NULL
members	NULL
of	NULL
the	NULL
runt	NULL
domain	NULL
gene-family	NULL
:	NULL
cDNA	NULL
structure	NULL
,	NULL
expression	NULL
,	NULL
and	NULL
chromosomal	NULL
localization	NULL
.	NULL

Genomics	NULL
23:425	NULL
,	NULL
1994	NULL
8	NULL
.	NULL

Avrham	NULL
K	NULL
,	NULL
Levanon	NULL
D	NULL
,	NULL
Negreanu	NULL
V	NULL
,	NULL
Bernstein	NULL
Y	NULL
,	NULL
Groner	NULL
Y	NULL
,	NULL
Copeland	NULL
N	NULL
,	NULL
Jerkins	NULL
N	NULL
:	NULL
Mapping	NULL
of	NULL
the	NULL
mouse	NULL
homolog	NULL
of	NULL
the	NULL
human	NULL
runt	NULL
domain	NULL
gene	NULL
,	NULL
AML2	NULL
,	NULL
to	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
chromosome	NULL
4	NULL
.	NULL

Genomics	NULL
25:603	NULL
,	NULL
1995	NULL
9	NULL
.	NULL

Calabi	NULL
F	NULL
,	NULL
Rhodes	NULL
M	NULL
,	NULL
Williamson	NULL
P	NULL
,	NULL
Boyd	NULL
Y	NULL
:	NULL
Identification	NULL
and	NULL
chromosomal	NULL
mapping	NULL
of	NULL
a	NULL
third	NULL
mouse	NULL
runt-like	NULL
locus	NULL
.	NULL

Genomics	NULL
26:607	NULL
,	NULL
1995	NULL
10	NULL
.	NULL

Wijmenga	NULL
C	NULL
,	NULL
Speck	NULL
N	NULL
,	NULL
Dracopoli	NULL
N	NULL
,	NULL
Hofker	NULL
M	NULL
,	NULL
Liu	NULL
P	NULL
,	NULL
Collins	NULL
F	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
new	NULL
murine	NULL
runt	NULL
domain-containing	NULL
gene	NULL
,	NULL
Cbfa3	NULL
,	NULL
and	NULL
localization	NULL
of	NULL
the	NULL
human	NULL
homolog	NULL
,	NULL
CBFA3	NULL
,	NULL
to	NULL
chromosome	NULL
1p35-pter	NULL
.	NULL

Genomics	NULL
26:611	NULL
,	NULL
1995	NULL
11	NULL
.	NULL

Kamachi	NULL
Y	NULL
,	NULL
Ogawa	NULL
E	NULL
,	NULL
Asano	NULL
M	NULL
,	NULL
Ishida	NULL
S	NULL
,	NULL
Murakami	NULL
Y	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Ito	NULL
Y	NULL
,	NULL
Shigesada	NULL
K	NULL
:	NULL
Purification	NULL
of	NULL
a	NULL
mouse	NULL
nuclear	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
both	NULL
the	NULL
A	NULL
and	NULL
B	NULL
cores	NULL
of	NULL
the	NULL
polyomavirus	NULL
enhancer	NULL
.	NULL

J	NULL
Virol	NULL
64:4808	NULL
,	NULL
1990	NULL
12	NULL
.	NULL

Meyers	NULL
S	NULL
,	NULL
Downing	NULL
JR	NULL
,	NULL
Hiebert	NULL
SW	NULL
:	NULL
Identification	NULL
of	NULL
AML-1	NULL
and	NULL
the	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
translocation	NULL
protein	NULL
(	NULL
AMLIA/ETO	NULL
)	NULL
as	NULL
se-quence-specific	NULL
DNA-binding	NULL
proteins	NULL
:	NULL
The	NULL
runt	NULL
homology	NULL
domain	NULL
is	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:6336	NULL
,	NULL
1993	NULL
2367	NULL
13	NULL
.	NULL

Wang	NULL
S	NULL
,	NULL
Speck	NULL
N	NULL
:	NULL
Purification	NULL
of	NULL
core-binding	NULL
factor	NULL
,	NULL
a	NULL
protein	NULL
that	NULL
binds	NULL
the	NULL
conserved	NULL
core	NULL
site	NULL
in	NULL
murine	NULL
leukaemia	NULL
virus	NULL
enhancers	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
12:89	NULL
,	NULL
1992	NULL
14	NULL
.	NULL

Leiden	NULL
J	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
genes	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
11:539	NULL
,	NULL
1993	NULL
15	NULL
.	NULL

Nuchprayoon	NULL
I	NULL
,	NULL
Meyers	NULL
S	NULL
,	NULL
Scott	NULL
L	NULL
,	NULL
Suzow	NULL
J	NULL
,	NULL
Hiebert	NULL
S	NULL
,	NULL
Friedman	NULL
A	NULL
:	NULL
PEBP2/CBF	NULL
,	NULL
the	NULL
murine	NULL
homolog	NULL
of	NULL
the	NULL
human	NULL
myeloid	NULL
AML1	NULL
and	NULL
proto-oncoproteins	NULL
,	NULL
regulates	NULL
the	NULL
murine	NULL
myeloperoxidase	NULL
and	NULL
neutrophil	NULL
elastase	NULL
genes	NULL
in	NULL
immature	NULL
myeloid	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:5558	NULL
,	NULL
1994	NULL
16	NULL
.	NULL

Zhang	NULL
D	NULL
,	NULL
Fujioka	NULL
K	NULL
,	NULL
Hetherington	NULL
C	NULL
,	NULL
Shapiro	NULL
L	NULL
,	NULL
Chen	NULL
H	NULL
,	NULL
Look	NULL
A	NULL
,	NULL
Tenen	NULL
D	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
region	NULL
which	NULL
directs	NULL
the	NULL
mono-cytic	NULL
activity	NULL
of	NULL
the	NULL
colony-stimulating	NULL
factor	NULL
1	NULL
(	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
)	NULL
receptor	NULL
promoter	NULL
and	NULL
binds	NULL
PEBP2/CBF	NULL
(	NULL
AML1	NULL
)	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:8085	NULL
,	NULL
1994	NULL
17	NULL
.	NULL

Takahashi	NULL
A	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Yamaguchi-Iwai	NULL
Y	NULL
,	NULL
Bae	NULL
S	NULL
,	NULL
Lu	NULL
J	NULL
,	NULL
Maruyama	NULL
M	NULL
,	NULL
Zhang	NULL
Y	NULL
,	NULL
Oka	NULL
H	NULL
,	NULL
Arai	NULL
N	NULL
,	NULL
Arai	NULL
K	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
Positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
activity	NULL
by	NULL
AMLJ-related	NULL
transcription	NULL
factor	NULL
,	NULL
PEBP2	NULL
.	NULL

Blood	NULL
86:607	NULL
,	NULL
1995	NULL
18	NULL
.	NULL

Kagoshima	NULL
H	NULL
,	NULL
Shigesada	NULL
K	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Ito	NULL
Y	NULL
,	NULL
Miyoshi	NULL
H	NULL
,	NULL
Ohki	NULL
M	NULL
,	NULL
Pepling	NULL
M	NULL
,	NULL
Gergen	NULL
P	NULL
:	NULL
The	NULL
runt	NULL
domain	NULL
identifies	NULL
a	NULL
new	NULL
family	NULL
of	NULL
heteromeric	NULL
transcriptional	NULL
regulators	NULL
.	NULL

Trends	NULL
Genet	NULL
9:338	NULL
,	NULL
1993	NULL
19	NULL
.	NULL

Ogawa	NULL
E	NULL
,	NULL
Maruyama	NULL
M	NULL
,	NULL
Kagoshima	NULL
H	NULL
,	NULL
Inuzuka	NULL
M	NULL
,	NULL
Lu	NULL
J	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Shigesada	NULL
K	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
PEBP2/PEA2	NULL
represents	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
homologous	NULL
to	NULL
the	NULL
products	NULL
of	NULL
the	NULL
Drosophila	NULL
runt	NULL
gene	NULL
and	NULL
the	NULL
human	NULL
AML1	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:6859	NULL
,	NULL
1993	NULL
20	NULL
.	NULL

Miyoshi	NULL
H	NULL
,	NULL
Ohira	NULL
M	NULL
,	NULL
Shimizu	NULL
K	NULL
,	NULL
Mitani	NULL
K	NULL
,	NULL
Hirai	NULL
H	NULL
,	NULL
Imai	NULL
T	NULL
,	NULL
Yokoyama	NULL
K	NULL
,	NULL
Soeda	NULL
E	NULL
,	NULL
Ohki	NULL
M	NULL
:	NULL
Alternative	NULL
splicing	NULL
and	NULL
genomic	NULL
structure	NULL
of	NULL
the	NULL
AML1	NULL
gene	NULL
involved	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
23:2762	NULL
,	NULL
1995	NULL
21	NULL
.	NULL

Tanaka	NULL
T	NULL
,	NULL
Tanaka	NULL
K	NULL
,	NULL
Ogawa	NULL
S	NULL
,	NULL
Kurokawa	NULL
M	NULL
,	NULL
Mitani	NULL
K	NULL
,	NULL
Nishida	NULL
J	NULL
,	NULL
Shibata	NULL
Y	NULL
,	NULL
Yazaki	NULL
Y	NULL
,	NULL
Hirai	NULL
H	NULL
:	NULL
An	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
gene	NULL
,	NULL
AML	NULL
1	NULL
,	NULL
regulates	NULL
hemopoietic	NULL
myeloid	NULL
cell	NULL
differentiation	NULL
and	NULL
transcriptional	NULL
activation	NULL
antagonistically	NULL
by	NULL
two	NULL
alternative	NULL
spliced	NULL
forms	NULL
.	NULL

EMBO	NULL
J	NULL
14:341	NULL
,	NULL
1995	NULL
22	NULL
.	NULL

Meyers	NULL
S	NULL
,	NULL
Lenny	NULL
N	NULL
,	NULL
Hiebert	NULL
S	NULL
:	NULL
The	NULL
t	NULL
(	NULL
8-21	NULL
)	NULL
fusion	NULL
protein	NULL
interferes	NULL
with	NULL
AML-1B-dependent	NULL
transcriptional	NULL
activation	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
15:1974	NULL
,	NULL
1995	NULL
23	NULL
.	NULL

Simeone	NULL
A	NULL
,	NULL
Daga	NULL
A	NULL
,	NULL
Calabi	NULL
F	NULL
:	NULL
Expression	NULL
of	NULL
runt	NULL
in	NULL
the	NULL
mouse	NULL
embryo	NULL
.	NULL

Dev	NULL
Dyn	NULL
203:61	NULL
,	NULL
1995	NULL
24	NULL
.	NULL

Satake	NULL
M	NULL
,	NULL
Nomura	NULL
S	NULL
,	NULL
Yamaguchi-Iwai	NULL
Y	NULL
,	NULL
Takahama	NULL
Y	NULL
,	NULL
Ha-shimoto	NULL
Y	NULL
,	NULL
Niki	NULL
M	NULL
,	NULL
Kitamura	NULL
Y	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
Expression	NULL
of	NULL
the	NULL
runt	NULL
domain-encoding	NULL
PEBP2	NULL
«	NULL
@	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
during	NULL
thymic	NULL
development	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
15:1662	NULL
,	NULL
1995	NULL
25	NULL
.	NULL

Tavassoli	NULL
M	NULL
:	NULL
Embryonic	NULL
and	NULL
fetal	NULL
hemopoiesis	NULL
:	NULL
An	NULL
overview	NULL
.	NULL

Blood	NULL
Cells	NULL
1:269	NULL
,	NULL
1991	NULL
26	NULL
.	NULL

Medvinsky	NULL
AL	NULL
,	NULL
Samoylina	NULL
NL	NULL
,	NULL
Muller	NULL
AM	NULL
,	NULL
Dzierzak	NULL
EA	NULL
:	NULL
An	NULL
early	NULL
pre-liver	NULL
intra-embryonic	NULL
source	NULL
of	NULL
CFU-S	NULL
in	NULL
the	NULL
developing	NULL
mouse	NULL
.	NULL

Nature	NULL
364:64	NULL
,	NULL
1993	NULL
27	NULL
.	NULL

Godin	NULL
IE	NULL
,	NULL
Garcia-Porrero	NULL
JA	NULL
,	NULL
Coutinho	NULL
A	NULL
,	NULL
Dieterlen-Lievre	NULL
F	NULL
,	NULL
Marcos	NULL
MAR	NULL
:	NULL
Para-aortic	NULL
splanchnopleura	NULL
from	NULL
early	NULL
mouse	NULL
embryos	NULL
contains	NULL
Bla	NULL
cell	NULL
progenitor	NULL
.	NULL

Nature	NULL
364:67	NULL
,	NULL
1993	NULL
28	NULL
.	NULL

Dzierzak	NULL
E	NULL
,	NULL
Medvinsky	NULL
A	NULL
:	NULL
Mouse	NULL
embryonic	NULL
hematopoiesis	NULL
.	NULL

Trends	NULL
Genet	NULL
11:359	NULL
,	NULL
1995	NULL
29	NULL
.	NULL

Okuda	NULL
T	NULL
,	NULL
van	NULL
Deursen	NULL
J	NULL
,	NULL
Hiebert	NULL
SW	NULL
,	NULL
Grosveld	NULL
G	NULL
,	NULL
Downing	NULL
JR	NULL
:	NULL
AML1	NULL
,	NULL
the	NULL
target	NULL
of	NULL
multiple	NULL
chromosomal	NULL
translocations	NULL
in	NULL
human	NULL
leukemia	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
normal	NULL
fetal	NULL
liver	NULL
hematopoiesis	NULL
.	NULL

Cell	NULL
84:321	NULL
,	NULL
1996	NULL
30	NULL
.	NULL

Wang	NULL
Q	NULL
,	NULL
Stacy	NULL
T	NULL
,	NULL
Binder	NULL
M	NULL
,	NULL
Marin-Padilla	NULL
M	NULL
,	NULL
Sharpe	NULL
AH	NULL
,	NULL
Speck	NULL
NA	NULL
:	NULL
Disruption	NULL
of	NULL
the	NULL
Chfa2	NULL
gene	NULL
causes	NULL
necrosis	NULL
and	NULL
hemor-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2368	NULL
thaging	NULL
in	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
and	NULL
block	NULL
definitive	NULL
hematopoiesis	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
93:3444	NULL
,	NULL
1996	NULL
31	NULL
.	NULL

Miyoshi	NULL
H	NULL
,	NULL
Kozu	NULL
T	NULL
,	NULL
Shimizu	NULL
K	NULL
,	NULL
Enomoto	NULL
K	NULL
,	NULL
Maseki	NULL
N	NULL
,	NULL
Kaneko	NULL
Y	NULL
,	NULL
Kamada	NULL
N	NULL
,	NULL
Ohki	NULL
M	NULL
:	NULL
The	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
translocation	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
results	NULL
in	NULL
production	NULL
of	NULL
an	NULL
AMLI-MTGS	NULL
fusion	NULL
transcript	NULL
.	NULL

EMBO	NULL
J	NULL
12:2715	NULL
,	NULL
1993	NULL
32	NULL
.	NULL

Tighe	NULL
J	NULL
,	NULL
Calabi	NULL
F	NULL
:	NULL
Alternative	NULL
,	NULL
out-of-frame	NULL
runt/MTG8	NULL
transcripts	NULL
are	NULL
encoded	NULL
by	NULL
the	NULL
derivative	NULL
(	NULL
8	NULL
)	NULL
chromosome	NULL
in	NULL
the	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
M2	NULL
.	NULL

Blood	NULL
84:2115	NULL
,	NULL
1994	NULL
33	NULL
.	NULL

Artlet	NULL
P	NULL
,	NULL
Morelle	NULL
C	NULL
,	NULL
Ausmeier	NULL
M	NULL
,	NULL
Fitzek	NULL
M	NULL
,	NULL
Hauser	NULL
H	NULL
:	NULL
Vectors	NULL
for	NULL
efficient	NULL
expression	NULL
in	NULL
mammalian	NULL
fibroblastoid	NULL
,	NULL
myeloid	NULL
and	NULL
lymphoid	NULL
cells	NULL
via	NULL
transfection	NULL
or	NULL
infection	NULL
.	NULL

Gene	NULL
68:213	NULL
,	NULL
1988	NULL
34	NULL
.	NULL

Morgenstern	NULL
J	NULL
,	NULL
Land	NULL
H	NULL
:	NULL
Advanced	NULL
mammalian	NULL
gene	NULL
transfer	NULL
:	NULL
High	NULL
titre	NULL
retroviral	NULL
vectors	NULL
with	NULL
multiple	NULL
drug	NULL
selection	NULL
markers	NULL
and	NULL
a	NULL
complementary	NULL
helper-free	NULL
packaging	NULL
cell	NULL
line	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
18:3587	NULL
,	NULL
1990	NULL
35	NULL
.	NULL

Gluzman	NULL
Y	NULL
:	NULL
SV40-transformed	NULL
simian	NULL
cells	NULL
support	NULL
the	NULL
replication	NULL
of	NULL
early	NULL
SV40	NULL
mutants	NULL
.	NULL

Cell	NULL
23:175	NULL
,	NULL
1981	NULL
36	NULL
.	NULL

Sambrook	NULL
J	NULL
,	NULL
Frisch	NULL
EF	NULL
,	NULL
Maniatis	NULL
T	NULL
:	NULL
Molecular	NULL
Cloning	NULL
.	NULL

A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
1989	NULL
37	NULL
.	NULL

Remaut	NULL
E	NULL
,	NULL
Stanssens	NULL
P	NULL
,	NULL
Fiers	NULL
W	NULL
:	NULL
Plasmid	NULL
vectors	NULL
for	NULL
high-efficiency	NULL
expression	NULL
controlled	NULL
by	NULL
the	NULL
p	NULL
;	NULL
promoter	NULL
of	NULL
coliphage-lambda	NULL
.	NULL

Gene	NULL
15:81	NULL
,	NULL
1981	NULL
38	NULL
.	NULL

Harlow	NULL
E	NULL
,	NULL
Lane	NULL
D	NULL
:	NULL
Antibodies	NULL
,	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
1988	NULL
39	NULL
.	NULL

Schlossman	NULL
S	NULL
,	NULL
Boumsell	NULL
L	NULL
,	NULL
Gilks	NULL
W	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Leucocyte	NULL
Typing	NULL
V	NULL
:	NULL
White	NULL
Cell	NULL
Differentiation	NULL
Antigens	NULL
.	NULL

Oxford	NULL
,	NULL
UK	NULL
,	NULL
Oxford	NULL
,	NULL
1994	NULL
40	NULL
.	NULL

Holmes	NULL
K	NULL
,	NULL
Langdon	NULL
W	NULL
,	NULL
Fredrickson	NULL
T	NULL
,	NULL
Coffman	NULL
R	NULL
,	NULL
Coffman	NULL
P	NULL
,	NULL
Hartley	NULL
J	NULL
,	NULL
Morse	NULL
H	NULL
:	NULL
Analysis	NULL
of	NULL
neoplasms	NULL
induced	NULL
by	NULL
CAS-BR-M	NULL
MuLV	NULL
tumor	NULL
extracts	NULL
.	NULL

J	NULL
Immunol	NULL
11:805	NULL
,	NULL
1986	NULL
41	NULL
.	NULL

Springer	NULL
T	NULL
,	NULL
Galfre	NULL
G	NULL
,	NULL
Secher	NULL
D	NULL
,	NULL
Milstein	NULL
C	NULL
:	NULL
Monoclonal	NULL
xe-nogeneic	NULL
antibodies	NULL
to	NULL
murine	NULL
cell	NULL
surface	NULL
antigens	NULL
:	NULL
Identification	NULL
of	NULL
novel	NULL
leukocyte	NULL
differentiation	NULL
antigens	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
8:539	NULL
,	NULL
1978	NULL
42	NULL
.	NULL

Ikuta	NULL
K	NULL
,	NULL
Kina	NULL
T	NULL
,	NULL
Mac	NULL
Neil	NULL
I	NULL
,	NULL
Uchida	NULL
N	NULL
,	NULL
Peault	NULL
B	NULL
,	NULL
Chien	NULL
Y	NULL
,	NULL
Weissman	NULL
I	NULL
:	NULL
A	NULL
developmental	NULL
switch	NULL
in	NULL
thymic	NULL
lymphocyte	NULL
maturation	NULL
potential	NULL
occurs	NULL
at	NULL
the	NULL
level	NULL
of	NULL
the	NULL
hematopoietic	NULL
stem-cells	NULL
.	NULL

Cell	NULL
62:863	NULL
,	NULL
1990	NULL
43	NULL
.	NULL

Coffman	NULL
B	NULL
:	NULL
Surface	NULL
antigen	NULL
expression	NULL
and	NULL
immunoglobulin	NULL
rearrangement	NULL
during	NULL
mouse	NULL
pre-B	NULL
cell	NULL
development	NULL
.	NULL

Immunol	NULL
Rev	NULL
69:5	NULL
,	NULL
1982	NULL
CORSETT	NULL
!	NULL

AND	NULL
CALABI	NULL
44	NULL
.	NULL

Gurdon	NULL
J	NULL
,	NULL
Partington	NULL
G	NULL
,	NULL
De	NULL
Robertis	NULL
E	NULL
:	NULL
Injected	NULL
nuclei	NULL
in	NULL
the	NULL
frog	NULL
oocytes	NULL
:	NULL
RNA	NULL
synthesis	NULL
and	NULL
protein	NULL
exchange	NULL
.	NULL

J	NULL
Embryol	NULL
Exp	NULL
Morphol	NULL
36:541	NULL
,	NULL
1976	NULL
45	NULL
.	NULL

Moore	NULL
M	NULL
,	NULL
Metcalf	NULL
D	NULL
:	NULL
Ontogeny	NULL
of	NULL
the	NULL
haemopoietic	NULL
system	NULL
:	NULL
Yolk	NULL
sac	NULL
origin	NULL
of	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
colony	NULL
forming	NULL
cells	NULL
in	NULL
the	NULL
developing	NULL
mouse	NULL
embryo	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
18:279	NULL
,	NULL
1970	NULL
46	NULL
.	NULL

Ogawa	NULL
M	NULL
,	NULL
Nishikawa	NULL
S	NULL
,	NULL
Yoshinaga	NULL
K	NULL
,	NULL
Hayashi	NULL
S	NULL
,	NULL
Kunisada	NULL
T	NULL
,	NULL
Nakao	NULL
J	NULL
,	NULL
Kina	NULL
T	NULL
,	NULL
Sudo	NULL
T	NULL
,	NULL
Kodama	NULL
H	NULL
,	NULL
Nishikawa	NULL
S	NULL
:	NULL
Expression	NULL
and	NULL
function	NULL
of	NULL
c-kit	NULL
in	NULL
fetal	NULL
hemopoietic	NULL
progenitor	NULL
cells	NULL
:	NULL
Transition	NULL
from	NULL
the	NULL
early	NULL
c-kit-independent	NULL
to	NULL
the	NULL
late	NULL
c-kit-dependent	NULL
wave	NULL
of	NULL
hemopoiesis	NULL
in	NULL
the	NULL
murine	NULL
embryo	NULL
.	NULL

Development	NULL
117:1089	NULL
,	NULL
1993	NULL
47	NULL
.	NULL

Nucifora	NULL
G	NULL
,	NULL
Rowley	NULL
J	NULL
:	NULL
AMLJ	NULL
and	NULL
the	NULL
8	NULL
;	NULL
21	NULL
and	NULL
3	NULL
;	NULL
21	NULL
translocations	NULL
in	NULL
acute	NULL
and	NULL
chronic	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Blood	NULL
86:1	NULL
,	NULL
1995	NULL
48	NULL
.	NULL

Golub	NULL
T	NULL
,	NULL
Barker	NULL
G	NULL
,	NULL
Bohlander	NULL
S	NULL
,	NULL
Hiebert	NULL
S	NULL
,	NULL
Ward	NULL
D	NULL
,	NULL
Bray-ward	NULL
P	NULL
,	NULL
Morgan	NULL
E	NULL
,	NULL
Raimondi	NULL
S	NULL
,	NULL
Rowley	NULL
J	NULL
,	NULL
Gilliland	NULL
D	NULL
:	NULL
Fusion	NULL
of	NULL
the	NULL
TEL	NULL
gene	NULL
on	NULL
12p13	NULL
to	NULL
the	NULL
AMLI	NULL
gene	NULL
on	NULL
21q22	NULL
in	NULL
acute	NULL
lymphoblastic-leukemia	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:4917	NULL
,	NULL
1995	NULL
49	NULL
.	NULL

Romana	NULL
S	NULL
,	NULL
Mauchauffe	NULL
M	NULL
,	NULL
Leconiat	NULL
M	NULL
,	NULL
Chumakov	NULL
I	NULL
,	NULL
Lepas-lier	NULL
D	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
Bernard	NULL
O	NULL
:	NULL
The	NULL
t	NULL
(	NULL
12	NULL
;	NULL
21	NULL
)	NULL
of	NULL
acute	NULL
lymphoblastic-leukemia	NULL
results	NULL
in	NULL
a	NULL
TEL-AML1	NULL
gene	NULL
fusion	NULL
.	NULL

Blood	NULL
85:3662	NULL
,	NULL
1995	NULL
50	NULL
.	NULL

Du-Bois	NULL
R	NULL
,	NULL
Bernaudin	NULL
J	NULL
,	NULL
Paako	NULL
P	NULL
,	NULL
Hubbard	NULL
R	NULL
,	NULL
Takahashi	NULL
H	NULL
,	NULL
Ferrans	NULL
V	NULL
,	NULL
Crystal	NULL
R	NULL
:	NULL
Human	NULL
neutrophils	NULL
express	NULL
the	NULL
alpha-1-antitrypsin	NULL
gene	NULL
and	NULL
produce	NULL
alpha-l-antitrypsin	NULL
.	NULL

Blood	NULL
77:2724	NULL
,	NULL
1991	NULL
51	NULL
.	NULL

Pevay	NULL
L	NULL
,	NULL
Lin	NULL
C	NULL
,	NULL
D'Agati	NULL
V	NULL
,	NULL
Simon	NULL
M	NULL
,	NULL
Orkin	NULL
S	NULL
,	NULL
Costantini	NULL
F	NULL
:	NULL
Development	NULL
of	NULL
hemopoietic	NULL
cells	NULL
lacking	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

Development	NULL
121:163	NULL
,	NULL
1995	NULL
52	NULL
.	NULL

Shivdasani	NULL
R	NULL
,	NULL
Mayer	NULL
E	NULL
,	NULL
Orkin	NULL
S	NULL
:	NULL
Absence	NULL
of	NULL
blood	NULL
formation	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
T-cell	NULL
leukaemia	NULL
oncoprotein	NULL
tal-1/SCL	NULL
.	NULL

Nature	NULL
373:432	NULL
,	NULL
1995	NULL
53	NULL
.	NULL

Warren	NULL
A	NULL
,	NULL
Colledge	NULL
W	NULL
,	NULL
Carlton	NULL
M	NULL
,	NULL
Evans	NULL
M	NULL
,	NULL
Smith	NULL
A	NULL
,	NULL
Rab-bitts	NULL
T	NULL
:	NULL
The	NULL
oncogenic	NULL
cystein-rich	NULL
LIM	NULL
domain	NULL
protein	NULL
rbtn2	NULL
is	NULL
essential	NULL
for	NULL
erythroid	NULL
development	NULL
.	NULL

Cell	NULL
78:45	NULL
,	NULL
1994	NULL
54	NULL
.	NULL

Tsai	NULL
F	NULL
,	NULL
Keller	NULL
G	NULL
,	NULL
Kuo	NULL
F	NULL
,	NULL
Weiss	NULL
M	NULL
,	NULL
Chen	NULL
J	NULL
,	NULL
Rosenblatt	NULL
M	NULL
,	NULL
Alt	NULL
F	NULL
,	NULL
Orkin	NULL
S	NULL
:	NULL
An	NULL
early	NULL
hematopoietic	NULL
defect	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
GATA-2	NULL
.	NULL

Nature	NULL
371:221	NULL
,	NULL
1994	NULL
55	NULL
.	NULL

Lu	NULL
J	NULL
,	NULL
Maruyama	NULL
M	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Bae	NULL
S	NULL
,	NULL
Ogawa	NULL
E	NULL
,	NULL
Kagoshima	NULL
H	NULL
,	NULL
Shigesada	NULL
K	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
Subcellular	NULL
localization	NULL
of	NULL
the	NULL
«	NULL
and	NULL
#	NULL
subunits	NULL
of	NULL
the	NULL
acute	NULL
myeloid	NULL
leukemia-linked	NULL
transcription	NULL
factor	NULL
PEBP2/CBF	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
15:1651	NULL
,	NULL
1995	NULL
56	NULL
.	NULL

Romana	NULL
S	NULL
,	NULL
Le	NULL
Coniat	NULL
M	NULL
,	NULL
Berger	NULL
R	NULL
:	NULL
t	NULL
(	NULL
12	NULL
;	NULL
21	NULL
)	NULL
:	NULL
A	NULL
new	NULL
recurrent	NULL
translocation	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
lymphoma	NULL
.	NULL

Genes	NULL
Chromosom	NULL
Cancer	NULL
9:186	NULL
,	NULL
1994	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

C	NULL
A	NULL
®	NULL
2	NULL
/	NULL
O	NULL
O	NULL
1997	NULL
89	NULL
:	NULL
2359-2368	NULL
Lineage-	NULL
and	NULL
Stage-Specific	NULL
Expression	NULL
of	NULL
Runt	NULL
Box	NULL
Polypeptides	NULL
in	NULL
Primitive	NULL
and	NULL
Definitive	NULL
Hematopoiesis	NULL
~	NULL
A	NULL
al	NULL
~	NULL
0	NULL
%	NULL
x	NULL
V	NULL
“	NULL
I	NULL
$	NULL
f	NULL
)	NULL
.	NULL

to	NULL
2101	NULL
%	NULL
N	NULL
®	NULL
Maria	NULL
Teresa	NULL
Corsetti	NULL
and	NULL
Franco	NULL
Calabi	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/89/7/2359.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Hematopoiesis	NULL
and	NULL
Stem	NULL
Cells	NULL
(	NULL
3573	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

